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Abstract
The effectiveness of treatments for degenerative spine conditions, where the primary
symptom is back pain, is typically determined using patient-reported quality of life (QoL)
measures. However, patients may adjust their internal standards when scoring QoL based
on factors other than their health. This response shift phenomenon could confound the
interpretation of study data and impact effectiveness conclusions. In the current study,
response shift was examined using structural equation modeling (SEM) and previously
collected clinical trial data comparing 2 minimally invasive medical devices in lumbar
spinal stenosis patients through 1 year postintervention. In subject QoL results,
reprioritization shift between 3 months and 12 months that could confound standard
analysis was identified. Treatment group did not influence response shift identified at 12
months. SEM provided an effective and practical tool for clinical investigators to assess
response shift in available clinical study data. As response shift could lead to invalid
conclusions when QoL measures are analyzed, clinical investigators should include
response shift assessment in the design of clinical trials. This research into how response
shift phenomenon can impact clinical trial results improves the ability of clinical
investigators to interpret clinical trial data, potentially preventing erroneous conclusions.
This research may also assist researchers and government regulators in the identification
and reimbursement of beneficial, cost-effective medical treatments for patients
worldwide. For clinical research designers, this study demonstrates a practical
application of response shift assessment.
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Chapter 1: Introduction to the Study
Health care reform, with its emphasis on evidence-based medicine, has focused
increased attention on the findings of clinical trials. Study conclusions influence multiple
aspects of health care including not just physicians selecting best treatment options, but
also regulators determining marketing approvals, and insurers making reimbursement
decisions. When objective biological or physiological markers are not practical or
available, clinical trials often rely on patient-reported outcomes (Hamidou, Dabakuyo, &
Bonnetain, 2011). These measures, captured through quality of life (QoL) and function
questionnaires, can introduce new challenges to data interpretation. Response shift
phenomenon, the adaptation over time in the way an individual perceives and scores his
or her health quality based on life events, can confound the comparison of longitudinal
scores and mask true change in trial data (Donaldson, 2005; Ring, Hofer, Heuston,
Harris, & O’Boyle, 2005).
Current researchers of response shift phenomenon have identified response shift
in a wide variety of conditions including cancer, stroke, and orthopedic pain (Copay et
al., 2010; Oort, Visser, & Sprangers, 2005; Mayo, Scott, Dendukuri, Ahmed, & WoodDauphinee, 2008), included theory and definitions (Razmjou, Schwartz, Yee, &
Finkelstein, 2009; Sprangers & Schwartz, 1999), and outlined a number of methodologies
for response shift identification (Ahmed, Mayo, Wood-Dauphinee, Hanley, & Cohen,
2005; McPhail & Haines, 2010b; Schwartz et al., 2011). However, the clinical
significance and practical assessment of response shift in randomized clinical trial data
has not been sufficiently investigated (Barclay-Goddard, Lix, Tate, Weinberg, & Mayo,
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2009). To provide clinical investigators with an enhanced ability to interpret clinical trial
data, research on the relative effect of response shift in comparative clinical trial results is
needed.
This chapter contains an outline of a research study of response shift phenomenon
in a randomized clinical trial that compared two interventions for lumbar spinal stenosis,
a degenerative spine condition. This summary includes an overview of the response shift
phenomenon body of knowledge, the research problem statement and purpose, and study
assumptions and limitations. More detailed study information including a literature
review and detailed study methodology can be found in Chapters 2 and 3.
Background
Clinical trials often use patient-reported outcomes, such as QoL measures, to
compare the efficacy and value of medical treatments (Houweling, 2010; Kvam, Wisløff,
& Fayers, 2010). However, when patient-reported outcome measures were included in
clinical trials, researchers identified paradoxical and illogical findings, such as ill patients
reporting the same QoL as healthy individuals (Li & Rapkin, 2009; Wilson, 1999).
Researchers have identified that response shift phenomenon, when individuals adapt the
way they score their health-related QoL based on factors other than treatment, can
complicate the interpretation of clinical trial results (Bernhard, Hürny, Maibach,
Herrmann, & Laffer, 1999; Hamidou et al., 2011; Osborne, Hawkins, & Sprangers, 2006;
Schwartz & Finkelstein, 2009). Specifically, this adaptation in the way an individual
understands and rates his or her well-being has been identified as a confounding factor in
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longitudinal studies of medical interventions (Donaldson, 2005; McPhail & Haines,
2010a; Razmjou et al., 2009; Schwartz et al., 2006).
In health care and QoL research, response shift has been defined as a change in
the meaning of self-reported outcome measures as a result of recalibration,
reprioritization, or reconceptualization (Sprangers & Schwartz, 1999, p. 1508).
Recalibration is the adaptation of an individual’s internal measurement standards.
Reprioritization occurs when the values of a respondent change and reconceptualization
is when a subject reinterprets a QoL concept that is used in the construct. As a natural
coping process in individuals, response shift can be either the goal of a behavioral
intervention, that is, improved adaptation to a chronic disease or disability; or a
confounding factor in medical research, that is, when patient-reported outcome measures
are compared pre- and postintervention (Schwartz, Andresen, Nosek, Krahn, & RRTC
Expert Panel on Health Status Measurement, 2007; Wilson, 1999).
Health care researchers have investigated response shift in a wide variety of
diseases and conditions. They have identified this phenomenon as an important
behavioral aspect of health care delivery for rehabilitation, geriatrics, and palliative care
(Osborne et al., 2006; Yardley & Dibb, 2007). Response shift has also been explored and
identified in specific disease conditions including cancer (Bernhard et al., 1999; Hamidou
et al., 2011; King-Kallimanis et al., 2012; King-Kallimanis, Oort, Visser, & Sprangers,
2009; Kvam et al., 2010), multiple sclerosis (King-Kallimanis, Oort, Nolte, Schwartz, &
Sprangers, 2011; Schwartz et al., 2011), dental treatment (Ring et al., 2005), and
orthopedic conditions (Haro, Maekawa, & Hamada, 2008; Razmjou, 2009). The effect of
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response shift on study data has ranged from small to moderate but has been shown to
have the ability to change clinical conclusions (Ring et al., 2005; Schwartz & Sprangers,
1999; Schwartz et al., 2006).
A variety of methods have been implemented to identify and quantify response
shift—design approaches including the then-test, individualized methods, preferencebased methods, and statistical approaches (Schwartz & Sprangers, 1999). Because
statistical methods allow simultaneous testing of multiple response shift hypotheses and
require only the study QoL instruments with no additional patient input, researchers have
used these techniques to examine available clinical trial data. The advanced technique of
structural equation modeling (SEM) has been successfully used to investigate response
shift phenomenon. Based on covariance multivariable regression, SEM has the ability to
explore all three components of response shift individually—reconceptualization,
reprioritization, and recalibration (Oort, 2005a). The SEM approach has also been applied
to address multiple timepoints and exogenous factors (Kline, 2011; King-Kallimanis,
Oort, & Garst, 2010; Oort et al., 2005). In health care, SEM has been used to explore
response shift in stroke, multiple sclerosis, and cancer (Barclay-Goddard, Lix, et al.,
2009; King-Kallimanis et al., 2012; King-Kallimanis et al., 2011, Oort et al, 2005)
This review of response shift phenomenon has highlighted that clinical
investigators typically do not evaluate response shift when assessing trial results and do
not understand the potential clinical significance of this phenomenon. While there has
been noteworthy research into this phenomenon, it is been addressed primarily from a
QoL perspective and not in a way that translates this information into current clinical trial
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design for randomized clinical trials or spine interventions. Therefore, further
examination of response shift with an emphasis on clinical significance and measurement
methodologies is needed to help guide comparative medical research and interpretation of
clinical trial data.
Problem Statement
In order to improve care and decrease costs, health care reform has increased
reliance on evidence-based medicine. For degenerative spine conditions where back pain
is the primary symptom, effectiveness is measured by patient-reported health care QoL.
However, the internal standards patients use to assess their QoL adapt over time and as a
result of their disease. While the scholarly literature has documented this phenomenon in
spine conditions (Copay et al., 2010), the clinical significance in randomized medical
device clinical trials has not been investigated. Specifically, there have been no studies
exploring the potential impact of response shift phenomenon in comparative spine
intervention studies when the decision endpoint is 1 year after the intervention.
Purpose of Study
The purpose of this study was to explore the impact on clinical trial conclusions
of response shift in lumbar spinal stenosis patients at 1 year postintervention. I evaluated
the relationship between the latent variables, physical QoL (PQoL) and mental QoL
(MQoL); and observed QoL variables from the Zurich Claudication Questionnaire
(ZCQ), Short Form General Health Survey (SF-12), Oswestry Disability Index (ODI) and
the pain Visual Analog Scale (VAS), in a structural equation model to assess response
shift. Using secondary data from baseline, 3 months, and 1 year, I explored the clinical
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significance of response shift by comparing this phenomenon between 3 months and 1
year and between two treatment groups.
Nature of Study
I used a quantitative longitudinal confirmatory modeling research design and QoL
data collected at three timepoints to support the investigation of the clinical significance
of response shift. The data used for this investigation were a subset of the data collected
as part of a randomized clinical trial comparing two lumbar spine medical devices. To
evaluate response shift, I performed confirmatory SEM techniques as a secondary
analysis on previously collected experimental data. By comparing response shift between
3 and 12 months and determining if there was a difference in the phenomenon identified
between these two points in time, I gained insights into the importance of considering
response shift in clinical data interpretation. In addition, investigating differences in
response shift at different timepoints increased my understanding of the role time plays in
this phenomenon. By evaluating response shift between treatment groups at 12 months, I
explored if a randomized clinical trial design changed the importance of considering
response shift in clinical studies. I selected this research study design because the study
population and modeling technique were aligned with the research requirements and the
methodology could be applied to existing data as a secondary analysis. By implementing
SEM techniques, I also assessed the practicality and usefulness of using this methodology
for response shift investigation.
To effectively investigate response shift, a population where response shift can be
expected was required. Spine treatment research has documented inconsistencies
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consistent with response shift phenomenon (Copay et al., 2010; Schwartz & Finkelstein,
2009). Patients who receive a lumbar spinal stenosis surgical intervention also meet the
criteria for a health state catalyst as defined by Sprangers and Schwartz (1999). A change
in health state is expected because the intervention is designed to relieve vertebral
pressure and reduce symptoms in patients currently experiencing debilitating back and
leg pain. Finally, as lumbar spinal stenosis is a progressive disease that interventions do
not fully resolve, the treatment effect is often partial and not total. Incomplete resolution
has also been identified as a factor in populations where responses shift is more likely to
be found (Finkelstein, Razmjou, & Schwartz, 2009).
This research also required an evaluation technique that supported the integration
of multiple observed variables and was sufficiently sensitive to identify the phenomenon
of interest. The statistical analytical approach of SEM met this criterion. When compared
to other available statistical techniques, SEM can address both measurement and
conceptual issues in a single model (Oort et al., 2009), can identify all three components
of response shift (Schwartz et al., 2011), and can address multiple follow-up timepoints
(Hamidou et al., 2011). This method does not require response shift specific data
collection and has been demonstrated in the literature (Barclay-Goddard, Lix, et al., 2009;
King-Kallimanis et al., 2011; Oort et al., 2005). Because few current comparative clinical
trials have addressed response shift directly, the ability to apply this methodology to
previously collected data increased the value of the research to on-going clinical trials.
For these reasons, a SEM technique using data from an on-going spine intervention study
was identified to support this investigation.
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Instead of independent and dependent variables, in structural equation models the
variables are termed latent and observed variables. The latent variables, factors not
directly measured, for this research included PQoL and MQoL. Observed variables
included the scores from QoL measures including the ZCQ, SF-12, ODI, and the pain
VAS. The exogenous variable of primary interest, a factor external to the model, was
treatment group, either the control or the investigational intervention. Additional
exogenous variables that were included in the exploratory analysis included age at time
of surgery, body mass index (BMI), gender, and number of levels treated (1 or 2).
The observed variables were provided from an on-going prospective, randomized,
controlled, multicenter trial titled Investigating Superion™ Interspinous Spacer in Spinal
Stenosis (ISISS). The ISISS study enrolled approximately 470 patients who (a) were at
least 45 years of age, (b) experienced moderate symptoms of neurogenic claudication
secondary to lumbar spinal stenosis, and (c) had documented stenosis at one or two
contiguous levels from L1 to L5 (VertiFlex, 2013). The ISISS trial completed enrollment
in 2012 and the data were submitted to the U.S. Food and Drug Administration (FDA) as
part of a premarket application. In the ISISS study, subjects who met all eligibility
criteria were randomized to either the investigational or a control device (1:1 ratio) and
had a medical device implanted. At each follow-up (6 weeks, 3 months, 6 months, 12
months, 18 months, and 24 months), study sites collected subject adverse event
information, radiographic images, a neurological assessment, and subject function and
QoL questionnaires. For this secondary research into response shift, only QoL data
through 12 months were included in the dataset and the specific treatment group
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(investigational or control) was blinded (coded as A or B) to safeguard the results of the
comparative performance of the two medical devices.
I used the SEM technique as presented by Oort (2005b) and King-Kallimanis et
al. (2010) to test for response shift in the ISISS prospectively collected data. Patientreported QoL and function data from subjects enrolled in the trial, that had a device
implanted, and were followed for 12 months were used in the three-step process. First, a
measurement model was established using SEM best practices (Kline, 2011). Then, I
tested the model for invariance across the measurement occasions of baseline, 3, and 12
months to identify response shift. Finally, I tested the model for invariance with respect
to the exogenous variables. The response shift results from the SEM analysis were then
used to address the research questions and hypotheses. Details of the research questions
and hypotheses are found in Chapter 3.
Research Questions
This study was designed to answer the following research questions:
1. Do treated back pain patients experience a difference in response shift
between baseline and 3 months and between baseline and 12 months
postintervention?
2. Does response shift phenomenon influence the clinical comparison of patientreported outcomes between baseline and 12 months in a randomized clinical
trial for a spine intervention?
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Hypothesis 1
H01: Response shift at 12 months is not different from response shift at 3 months.
RS12 = RS3
Ha1: Response shift at 12 months is different from response shift at 3 months.
RS12 ≠ RS3
Hypothesis 2
H02: Response shift found in the patient-reported outcome results for treatment
group A at 12 months is not different from the response shift in treatment group B at 12
months.
RSA = RSB
Ha2: Response shift found in the patient-reported outcome results for treatment
group A at 12 months is different from the response shift in treatment group B at 12
months.
RSA ≠ RSB
Theoretical Foundation
This research was based on two foundational concepts—response shift theory and
SEM. Response shift, a psychological adaptation to situations, was first identified in the
1970s in research in management science and educational training (Schwartz, Sprangers,
& Fayers, 2005). Modern investigation of response shift was facilitated in the 1990s by
the updated theory proposed by Sprangers and Schwartz (1999) that translated research
into QoL measures associated with the evaluation of disease progression and assessment
of medical treatments. The earliest descriptions of response shift focused on internal
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changes in an individual’s standards of measurement (Howard & Dailey, 1979) and
separating true change from changes in internal standards and meaning (Golembiewski,
Billingsley, & Yeager, 1976). Sprangers and Schwartz expanded these concepts to
provide a working definition of response shift with a goal of supporting the development
of reliable and valid measures for assessing changes in QoL measures. Response shift
addresses the paradoxical and counter-intuitive research findings in the QoL literature
including consistent discrepancies between clinical measures and patient-reported QoL.
Grounded in control theory and self-regulating systems, the theoretical model included a
dynamic feedback loop where an individual’s behavioral processes used to handle life
events (mechanisms) worked with the individual’s characteristics (antecedents) in a way
that resulted in a QoL result that differed from the expectations based on objective
criteria (response shift). Catalysts in this theory included changes in the patient’s health
status, either positive or negative. Antecedents are a person’s stable characteristics such
as gender and personality, and mechanisms refer to cognitive processes that the patient
uses to adjust to life changes. Finally, QoL is the measurement construct that scores the
patient’s feelings about his or her life and response shift is a person’s change in
perspective when evaluating his or her QoL. QoL researchers have identified
recalibration, reprioritization, and reconceptualization as components of response shift
(Sprangers & Schwartz, 1999). The theoretical foundation of response shift is explored in
more detail in Chapter 2.
Modeling provides the methodological foundation for this research. SEM is a
family of multivariate analysis procedures that focus on means, variances, and
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covariances to explore relationships between observed and latent (unobserved) variables.
Confirmatory factor analysis, a SEM model, is used to determine if collected data fit a
theory-based measurement model. Based on covariance, the procedure is designed to
accomplish two goals: (a) to understand the patterns of covariance and (b) to use the
researcher-specified model to explain as much of the variation as possible (Kline, 2011).
SEM is implemented by hypothesizing a causal model, depicting the model as a path
diagram, and testing the model using empirical data. This technique incorporates
measurement error as latent variables and allows variables to be indicated by multiple
measures. The combination of structural path models, factor analysis, and covariance
analysis enables SEM to address the complex interactions typical in social science
research questions.
The variables that can be included in a structural equation model support the
complexity of social science research. Variables may be observed or unobserved (latent)
with some of the latent variables representing measurement error (Kline, 2011). The scale
of a latent variable is arbitrary and the researcher must set the value in the model. By
setting the variance of a latent variable to 1, the scale can be standardized. Alternatively,
the variable may take on the scale of one of its indicator variables (Lei & Wu, 2007).
These conventions allow for simplification because when fixed in either manner, the
variables are not estimated from the data. Similarly, because for endogenous variables all
effects are included in the model, no unanalyzed associations occur between these
variables (Kline, 2011).
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When applied to response shift and health care research, SEM strengths include
the ability to incorporate multiple variables into the model, the inclusion of measurement
error, and the fact that this technique can be applied without additional data collection.
Finally, because in the social sciences the magnitude of the effect is often most important
and not the specific result of the statistical test, SEM provides better estimates of effect
size for observed variables than many other mathematical techniques (Kline, 2011).
Additional discussion of SEM and a detailed methodology for this research study are
included in Chapter 3.
Definitions
Correlation matrix: Representation of data in a structural equation model for
programming and model specification (Kline, 2011, pp. 48-49).
Endogenous variable: A model component (variable) that is influenced by another
variable in the model—a dependent variable (Kline, 2011, p. 96).
Exogenous variable: A model component (variable) not influenced by another
variable in the model—an independent variable (Kline, 2011, p. 95).
Health-related quality of life (QoL): “A multidimensional concept that usually
includes self-report of the way in which physical, emotional, social, or other domains of
well-being are affected by a disease or its treatment” (Calvert et al., 2013, p. 815).
Latent variable: A model component (variable) that is not directly measured or
observed. Latent variables can also be called factors (Ullman, 2006, p. 36).
Measurement model: A system depiction (model) that relates measurement
variables to latent variables (Ullman, 2006, p. 37).

14
Observed variable: A model component (variable) that is directly observed or
measured. Observed variables can also be called indicators, measured variables, or
manifest variables (Ullman, 2006, p. 36).
Response shift phenomenon: A change in the meaning of an individual’s selfreported outcome measures such as QoL and function. Specifically, “a change in the
meaning of one’s self-evaluation of a target construct as a result of: (a) a change in the
respondent’s internal standards of measurement (scale recalibration, in psychometric
terms); (b) a change in the respondent’s values (i.e. the importance of component
domains constituting the target construct); or (c) a redefinition of the target construct (i.e.
reconceptualization)” (Sprangers & Schwartz, 1999, p 1508).
Structural equation modeling (SEM): A set of modeling techniques based on
correlation and matrixes with the potential to differentiate between observed and latent
variables (Kline, 2011, pp. 7-9). This research focuses on a common SEM technique,
confirmatory factor analysis (CFA), that integrates a measurement and a structural model.
Structural model: A system depiction (model) that documents the hypothesized
relationships between all the variables of the model (Ullman, 2006, p. 37).
Quality of life (QoL): “The general well-being of a person or society, defined in
terms of health and happiness, rather than wealth” (Collins English Dictionary, n.d.).
Scope of Research
Through this research, I explored the potential impact of response shift
phenomenon in a comparative spine intervention with a decision endpoint 1 year after the
intervention. The primary ISISS study represented the population of patients in the
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United States that is seeking minimally invasive treatment for radiographically confirmed
moderate lumbar spinal stenosis. Lumbar spinal stenosis is the most common indication
for spinal surgery in adults over age 65 with lumbar spinal stenosis in 20% of U.S. adults
over age 60 and 80% in those over age 70 (Loguidice, Bini, Shabat, Miller, & Block,
2011). This response shift research, a secondary evaluation, represented the same
population as data from all subjects that completed 12-month follow-ups as of February
2012 were included in the analysis.
Delimitations
Data from a single lumbar spinal stenosis intervention study were used to support
this research. All subjects were enrolled between June 2008 and Feb 2012 from 32
geographically dispersed sites in the United States (Loguidice et al., 2011; VertiFlex,
2013). Generalization concerning response shift in other intervention studies, other spine
conditions, and other diseases were not considered. Additionally, adverse event
information, radiographic, and neurological evaluation results were not be correlated with
QoL data because it was beyond the scope of the research.
Assumptions
A key assumption of this research was that the primary clinical study data from
ISISS were high quality and could be used to support this response shift research. As a
subset of previously collected data, the limited dataset has the same quality
characteristics as the original research. Because the ISISS study was designed to provide
data for an FDA submission for commercialization, it included compliance with good
clinical practice and all federal regulations associated with medical device clinical studies
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including 21 Code of Federal Regulations (CFR) Parts 50, 54, 56, and 812 (VertiFlex,
2013). The electronic case report form data collection system was in compliance with 21
CFR Part 11. As required by 21 CFR 812 and good clinical practice, quality control
techniques, periodic site monitoring, and source data verification were included in the
data collection process.
Another assumption was that the methodology used to assess response shift was
sufficiently sensitive to the phenomenon. Because sample size and power analysis are not
applicable to advanced modeling techniques such as SEM to determine sensitivity, other
support was required. A comparative evaluation of three statistical techniques for
measuring response shift identified SEM as being the most successful and providing
interpretable findings (Schwartz et al., 2011). Best practices for implementing SEM were
integrated into the analysis process and are addressed in more detail in Chapter 3.
Limitations
This research was based on secondary analysis of previously collected
experimental clinical trial data. As such, this research design did not drive the data
collection. Additionally, the data for this research were collected prior to final quality
checks so there was a possibility of data entry errors. These concerns have been mitigated
by ensuring that the source data were collected in accordance with good clinical
practices, included electronic data entry with built-in edit checks, and had been monitored
by the sponsor. Additionally, data screening and cleaning procedures were used prior to
analysis.
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Advanced modeling also introduces limitations to a research design. Consistent
with standard modeling techniques, the determination of goodness of fit and
respecification of the structural equation model is dependent on the researcher’s
subjective judgment. The research design minimized this limitation by prespecifying
alternative models and ensuring all model adjustments were supported by theoretical
justifications (Kline, 2011).
Significance of Study
This research provides clinical investigators with a practical application of a
response shift assessment in a clinical trial and adds to the body of knowledge on
response shift phenomenon. For clinical investigators, especially spine researchers, the
role of response shift in study findings is highlighted and instruments most likely to be
impacted by response shift are identified. This increased knowledge on how to improve
clinical trial design to enable the separation of true change from patient adaptation will
result in clinical investigators making more accurate conclusions and enhance clinical
decision-making. This improved clinical evidence would support the approval and
reimbursement of effective, cost-effective treatments and interventions.
This evaluation of response shift in a lumbar spinal stenosis population provides
QoL researchers with additional data from patients with a chronic condition and
addresses the impact of time as a catalyst variable. The demonstration of a practical
methodology supported the integration of response shift assessment into clinical trial
design. The results supported better understanding of how patients respond to changes in
their health state and enable physicians to support improved QoL adjustment for
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individuals living with chronic diseases or disabilities. Enhanced understanding of QoL
results and a practical methodology could also be translated back to management research
where patient-reported QoL information was included in the analysis.
Summary
Response shift phenomenon, changes in a patient’s internal standards when
assessing health-related QoL over time, may impact clinical trial results and conclusions
used to support health care decision-making. This chapter examined response shift,
including current theory, methods of evaluation, and the potential impact of response
shift on the data interpretation, and presented a research study to explore this
phenomenon. I identified the use of mathematical modeling, specifically SEM, as one
method to assess and determine the incidence and impact of response shift in clinical
data. The research problem, hypotheses, assumptions, potential limitations, and research
definition were outlined. A review of the significance of this research to society
concluded the chapter. Further explanation and clarification will be found in subsequent
chapters.
Response shift may present a significant confounding factor in clinical trials that
use patient-reported outcomes as primary endpoints. However, much remains to be
characterized about this phenomenon. This research into the impact of response shift in a
spine intervention clinical trial provides valuable information to health care and QoL
researchers and includes a practical methodology for response shift assessment. To
explore the body of knowledge on response shift phenomenon in more depth, Chapter 2
contains a comprehensive literature review of this phenomenon. In Chapter 3, I outline
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the detailed methodology and provide the results of the analysis in Chapter 4. Finally, I
discuss the findings and provide practice and future research recommendations in
Chapter 5.
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Chapter 2: Literature Review
To translate new medical research and technologies into effective treatments and
enhanced patient care, clinical trials play a pivotal role. However, when patient-reported
outcomes serve as the primary study endpoints, confounding factors may complicate or
even invalidate the interpretation of study results (Donaldson, 2005; Hamidou et al.,
2011). One potential influencing factor is response shift phenomenon—the fact that, over
time and based on life events, individuals can change the way they perceive and report
their well-being based on factors unrelated to their health state (Sprangers & Schwartz,
1999). To draw effective conclusions from randomized, comparative health care data,
researchers must understand the impact and clinical significance of this phenomenon.
Studies of degenerative spine treatments, where pain is the primary symptom and
effectiveness is measured by patient-reported health care QoL measures, may be
impacted by response shift (Don & Carragee, 2008; Schwartz & Finkelstein, 2009). Only
by incorporating the assessment of response shift into clinical trial design will clinical
investigators and researchers be able to consistently and effectively assess the best, most
effective treatment options for patients.
To explain paradoxical and counterintuitive findings between objective measures
and patient-reported outcomes, QoL researchers developed response shift theory
(McPhail & Haines, 2010a; Schwartz et al., 2006). In health care research, this
phenomenon has been identified in a wide variety of conditions including cancer (Oort et
al., 2005), stroke (Mayo et al., 2008), and lumbar spinal stenosis (Copay et al., 2010). In
separate comprehensive overviews, Schwartz and Sprangers (1999), Ahmed et al. (2005),
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McPhail and Haines (2010a), and Schwartz et al. (2011) identified a number of
methodologies used to investigate and quantify response shift including design
approaches, individualized methods, preference-based methods, and statistical
techniques. The mechanisms and processes of response shift have been researched in
many ways though the clinical significance to randomized clinical trial data and the
effective transfer of assessing this phenomenon have not yet been supported. A promising
approach is the statistical method of SEM (King-Kallimanis et al., 2010; Kline, 2011;
Oort et al, 2005). Based on the working definition proposed by Schwartz and Sprangers
(1999), this review analyzes response shift in health care research. The key aspects
associated with this phenomenon include the theory and foundations, response shift in
health care and spine research, measurement approaches, and SEM as applied to response
shift. This review provides insights to assist clinical investigators, clinical trial designers,
and health care professionals to understand the clinical importance of response shift and
to effectively integrate the assessment of response shift into trials thereby improving the
quality of care for patients.
I conducted a comprehensive literature search to support this review. Using three
primary databases, EBSCO Academic Search Premier, ProQuest Complete, and Science
Direct, I searched for articles using the terms response shift, health related QoL, patientreported outcomes, measurement bias, SEM, statistical analysis, longitudinal data,
orthopedics, and spine clinical trials and combined these terms using Boolean operators
to better target relevant articles. I gave preference to peer-reviewed articles published
between 2008 and 2014; however, I also included earlier foundational research,
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specifically from 2005 and 1999. I screened the bibliographies of the research articles to
identify additional sources, key words, and relevant concepts and used Zotero, a
bibliography management program, to categorize and document articles.
Response Shift Theory
Experiencing and responding to change is part of every individual’s life
experience. In the past 15 years, physicians and medical researchers have become
increasingly interested in the way a person’s health state affects his or her QoL
perception, especially changes from treatment or disease progression. Sprangers and
Schwartz (1999) defined response shift phenomena as the adaptation of a respondent’s
internal standards, values, and conceptualization of life quality due to changing health or
other life events. Used to understand and explain unanticipated or illogical relationships
between objective measures and patient-reported health care QoL, the discipline of
response shift is still in an early developmental stage. The complexities of response shift
phenomenon and researchers’ conceptual and operational confusion have created
challenges in research. Despite this, the body of knowledge is diverse and has supported
multiple theories, a variety of assessment methodologies, and increased understanding of
the clinical significance of response shift in clinical trials, especially in the area of QoL
assessment.
Origin of Response Shift Theory
Howard and Dailey (1979) first identified response shift bias while documenting
the benefits of educational training programs. Envisioned as an instrumentation effect,
the researchers argued that because the purpose of a training program was to change a
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subject’s knowledge of a specific variable, typically an attribute being measured, a
successful program would alter the individual’s perspective and impact self-evaluations.
With a change in a respondent’s internal measurement standards and scales, the
assumption of a common yardstick for the two assessments would be violated. The
individual’s adaption could then confound or even invalidate the standard technique of
direct comparison of pre- and posttraining self-evaluations. Recognizing the same
phenomenon in organizational research, other early theorists classified and defined types
of change. Golembiewski et al. (1976) postulated three types of change—alpha, beta, and
gamma. Alpha change was identified as true change, the goal of the treatment or
intervention. Beta and gamma change were potential bias factors that indicated scale
recalibration and construct reconceptualization. Through statistical analysis, the authors
concluded that a single concept of change was not appropriate and noted that failure to
account for individual adaptation could result in inaccurate data interpretation and
erroneous conclusions.
Building upon these foundations, Sprangers and Schwartz (1999) translated
response shift into health care research and developed a theoretical model based on
control theory. An individual’s psychological adaptation to illness was modeled as a
continuous feedback system with the goal being the individuals feeling as good as
possible about themselves and their life. The model included five primary variables—
catalysts, antecedents, mechanisms, response shift, and perceived QoL. Catalysts were
the changes in an individual’s health state, regardless of source or direction. These
changes could be the result of sudden onset of illness, initial diagnosis, disease
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progression, or treatment. Antecedents were the built-in, existing characteristics of the
individual such as gender, personality, and spiritual identity. Mechanisms were the
processes the individual would use to respond to the catalyst including coping, social
support, and goal reordering. Response shift was the adaptation of the person’s meaning
of QoL resulting from changes in internal standards, values, or well-being concepts.
Perceived QoL was the final multidimensional construct of the person’s well-being that
incorporated physical, mental, social, and other aspects of living. Sprangers and Schwartz
theorized that when faced with a change in health status (catalyst), an individual will use
known mechanisms influenced both directly and indirectly by antecedents to trigger
response shift. The divergence of reported QoL from objective criteria-based
expectations would therefore be directly impacted by response shift. The model,
highlighting the feedback loop within the individual, is presented in Figure 1.

Figure 1. Sprangers and Schwartz response shift feedback loop. Based on description in
“Integrating response shift into health-related quality of life research: A theoretical
model,” by M. Sprangers and C. Schwartz, 1999, Social Science & Medicine, 48, pp.
1507-1515.
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Alternative theories of response shift have also been proposed. Carver and Scheier
(2000) described a theory for the recalibration component of response shift based on
adaptive self-regulation. In the model, when an individual experienced a health state
adversity associated with distress that could not be resolved, the individual’s well-being
reference point would scale back or down. For example, a person who ran competitive
10K races would not expect to compete while they were healing from a broken leg. By
reducing expectations and aspirations, the person would again experience both positive
and negative feelings around the new set point replacing the mostly negative feelings
based on the old reference. Carver and Scheier viewed the change as automatic, outside
of voluntary control, and relatively slow. The authors supported the importance of human
response shift by arguing that without recalibration, individuals would not be able to
overcome life-changing adversity and concluded that human well-being was tied to
having purpose in life, and purpose was supported by response shift. Addressing response
shift differently, Wilson (1999) proposed investigating how the dimensions of subject
well-being including biological measures, symptoms, functioning, and general health
perceptions, change relative to each other. In this construct, response shift would be
considered an effect that cannot be attributed to the disease or to known mechanisms,
therefore a placebo effect. Wilson also identified that response shift was a goal of routine
clinical practice since it supported the physician or non-conventional practitioner in
allowing the patient to cope with their current health state. Despite the alternative
viewpoint, the author validated the importance of response shift in clinical care and
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concluded that producing response shift involved understanding the context of the illness,
could be impacted by the physician-patient relationship, and could improve patient QoL.
As an early discipline, the conceptual and operational definitions of response shift
theory are still being explored. Complementary and competing theories, such as crisis
theory and implicit theories including recall bias, impression management, and effort
justification have been identified (Mayo et al., 2008; Sprangers & Schwartz, 1999).
Researchers have proposed multiple directions for future research to address theory,
application, and reporting. Multiple researchers identified a requirement to build a
consensus on terminology (Barclay-Goddard, Epstein, & Mayo, 2009, Reeve, 2010;
Schwartz et al., 2005). Schwartz et al. (2005) also highlighted that exploring the timing
and nature of catalysts and investigating the relationship between the components of
response shift would support expanded theory. Integration into health care clinical trials
would benefit from research into surrogate markers, additional measurement and
adjustment techniques, optimal follow-up timepoint identification, and bias-minimizing
study designs (Hamidou et al., 2011). Standard reporting of critical response shift
parameters to include data on effect size, sample size and response rates, and details of
instrument psychometrics would support the transfer of knowledge both within and
across disciplines (Schwartz et al., 2006). Finally, Schwartz et al. (2006) emphasized that
researchers should always provide information on how the study results could impact
future research and, if applicable, provide clear interpretation guidelines for
generalization.
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Definition of Response Shift
Sprangers and Schwartz (1999) provided a working definition of response shift
that has grounded most health care research into this phenomenon. The authors specified
that response shift referred to a change in the meaning of self-reported outcome measures
as a result of recalibration, reprioritization, or reconceptualization (p. 1508).
Recalibration occurs when an individual changes their internal measurement standards,
i.e. the worst pain imaginable reference point gets higher after the patient experiences
kidney stones. Reprioritization ensues when an individual changes what they value, i.e.
family support and social connections become more important than appearance after
chemotherapy results in hair loss. Reconceptualization transpires when an individual
changes how they interpret a specific concept, i.e. originally physical function and mental
health were primary components of QoL, after disease diagnosis and treatment the level
of fatigue experienced better defines a good day. This definition has provided a
foundation for the investigation and understanding of response shift in health care.
Response shift researchers have been challenged by the complexity of the
phenomenon and potential overlap with other coping phenomena. Schwartz et al. (2005)
felt the need to address a very basic question—is response shift an umbrella term for
different phenomena that should be studied separately or is it an important new concept
for QoL research? While noting further research and theory were required, the authors
pointed out that if response shift could explain away all paradoxical or unexpected results
from patient-reported data then it would have no meaning. Consequently, the researchers
recommended that alternative theories should be explored before labeling a finding as
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response shift. In the QoL research community, a wide variety of operational definitions
have been associated with response shift even when the same working definition was
applied. To support analysis, Schwartz et al. identified six primary areas of dispute
concerning the dimensions of response shift. These areas covered how best to define
response shift and what uniquely identified the phenomenon. The issues were not
mutually exclusive and are outlined in Table 1.
Table 1
Response Shift Perspectives
Perspective 1
Bias
(to be corrected for)
Measurement characteristic
(error in instrument selection)
Ad hoc explanation
(for illogical findings)
Temporary change

Perspective 2
Meaningful change
(worth investigation)
Subject characteristic

5

Result of a catalyst

Result of passage of time

6

Events unrelated to health state may
be relevant to response shift

Only health-related events are
relevant to response shift

1
2
3
4

Phenomenon
(to be studied)
Permanent change

Highlighting that when comparing two QoL scores the goal of QoL researchers
was to determine what was change in QoL and what was measurement error, Ubel,
Peeters, and Smith (2010) proposed that the term response shift be replaced with
something less ambiguous. Arguing that since response shift as currently used lumped
together measurement error and true QoL changes, Ubel et al. claimed the use of a single
term impeded QoL research by creating conceptual confusion. The researchers also
identified logical circularity since the operationalization of the mechanism was the same
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as the operationalization of response shift and that there was an implied connotation that
response shift was a threat to the validity of self-reported data. Other researchers
including Sprangers and Schwartz (2010) and Reeve (2010) agreed that there was
conceptual confusion surrounding response shift but disagreed with the primary
recommendation of abandoning the term. Sprangers and Schwartz highlighted that
abandoning response shift terminology would not resolve the outlined problems as it
mixed human adaptation processes and measured outcomes and that new approaches,
some already in press, could address areas of concern. Reeve concurred with Sprangers
and Schwartz that a change of terms was not the solution but agreed with Ubel et al. that
there was confusion surrounding the phenomenon. Reeve’s recommendations included
focusing on educating researchers on terms and the implications of incorporating QoL
change as endpoint variables. Researchers could improve research quality by including in
study planning an assessment of (a) the QoL construct, (b) the measurement instrument,
(c) research study design, (d) the subjects participating in the study, and (e) the
investigator interpretation of the data.
Expansion to Theory
Expansions to response shift theory have focused on the methods individuals use
to grade their well-being (the appraisal process) and classifying the measurement and
explanation components of response shift. Rapkin and Schwartz (2004) adapted a
psychological adjustment process to create a four-step procedure for determining an
individual’s appraisal process included (a) assessing the frame of reference, (b)
identifying a subjective sampling strategy, (c) recognizing standards of comparison, and
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(d) understanding the combinatory algorithm. The authors concluded that recognizing the
appraisal process was a step in relating patient-reported outcomes to external observer
perspectives and was an important aspect of understanding response shift phenomena. In
related research by the same authors, Schwartz and Rapkin (2004) created a psychometric
model integrating the appraisal process into QoL true score assessment and evaluation of
questionnaire properties. To improve research, the authors proposed designing new
instruments that included appraisal aspects, using appraisal features to stratify subjects,
and including appraisal constructs into clinical trials as moderating variables.
In another theory expansion, Oort et al. (2009) explored and defined the concepts
of response shift as either measurement or explanation bias, two separate but related ideas
researchers have used to classify response shift. From a measurement perspective,
response shift would be a special case of measurement bias. Measurement bias involved
the idea that the instrument used, the questionnaire, does not perfectly measure the
attribute of interest. Therefore due to this mismatch, changes in the test results were not
fully determined by changes in the characteristic of interest. This would identify response
shift as a difference in the scores that was not explained by true differences but was also
not random, a violation of measurement invariance. From a conceptual perspective,
response shift would be a special case of explanation bias. Here there was a distinction
between predictors of the construct and other variables that might impact the construct.
This perspective identified response shift as variance in the scores that was not explained
by the model variables but was also not random, a violation of explanation invariance.
Oort et al. identified that the primary difference in these two perspectives would impact
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the classification of the type of response shift that had been realized in a specific
situation—recalibration, reprioritization, or reconceptualization. The researchers
concluded that since both perspectives had meaning and value, response shift
measurement methodologies that addressed both aspects would be preferred for response
shift investigation, especially if the components of response shift could be investigated
both jointly and separately. By investigating and classifying these perspectives, response
shift theorists have distinguished different schools of thought concerning response shift,
helped to resolve confusion in the research community, and highlighted different research
methodologies.
Response Shift in Health Care
Any instrument that captures self-reported data from individuals may be impacted
by response shift (Wilson, 1999). And with the importance of evidence driving the
integration of QoL assessments into clinical research and paradoxical findings indicating
that further exploration was required (Oort et al., 2009; Sprangers & Schwartz, 1999), the
health care research community has been motivated to explore this phenomenon in
greater detail. Reviewing the role of the QoL research community, use in behavioral
research, and disease specific studies will provide important background for response
shift investigation.
QoL Research
As treatment and intervention decisions are increasingly guided by evidencebased medicine, physicians and clinical researchers have developed methods to assess
how patients perceive their care and well-being. Health-related QoL has been used to
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assess the clinical benefit of interventions and recognized as a valid clinical endpoint by
the medical community (Barclay-Goddard, Epstein, et al., 2009). In cancer research, the
U.S. FDA has recommended that health-related QoL assessments be included in clinical
research since 1985 (Hamidou et al., 2011). As patient-reported outcomes have grown to
encompass patient symptoms, functioning, perceptions of health status, and overall wellbeing, the QoL research subspecialty has developed to increase knowledge in this
discipline. In order to explain counterintuitive QoL findings, researchers from this
discipline introduced response shift and have supported significant research into this
phenomenon in health care (Sprangers & Schwartz, 1999; Wilson, 1999). Questions
asked by the community (Oort et al., 2009; Schwartz et al., 2005) include
•

Is response shift associated with measurement or subject characteristics?

•

Should response shift be corrected for or studied?

•

Is response shift an ad hoc explanation for counterintuitive findings?

•

What initiates response shift?

Schwartz et al. (2005) identified three primary reasons that response shift phenomenon
should be measured. First, failure to account for response shift could lead to inaccurate
treatment effect conclusions in clinical trials. Second, response shift could impact
determination of minimal clinical significant change. This concept used to identify
thresholds for meaningful improvement recognized that just because change was
measureable did not mean it was useful or valuable to individuals. Finally, measuring
response shift would provide insight into the human adaptation process resulting in more
ways to support patients in effective chronic diseases and disabilities accommodation.
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With a focus on the phenomenon of response shift itself, the body of research has
been primarily academic. Empirical and clinical data have been presented to illustrate
relevant response shift concepts and not to develop practical methods of incorporating
response shift into clinical trial design (Barclay-Goddard, Epstein, et al., 2009; Schwartz
et al., 2006).
Behavioral Research
An important aspect of clinical care has been determining how effective
interventions have been in modifying the behavior and medical outcomes of patients.
This was also an area where response shift was first identified. Health care researchers
have therefore explored response shift in a variety of applications including modification
of behavior and coping with chronic conditions.
Behavior modification for fall prevention, pulmonary rehabilitation, and cancer
survivor intervention has been examined for the presence and impact of response shift.
McPhail and Haines (2010b) evaluated response shift in a study of hospitalized patients
participating in a fall prevention program. Two QoL questionnaires were completed, one
within 3 days of hospital admission and one immediately prior to discharge. This older
population, mean age of 73.3 years, had a median length of stay of 38 days (range 20-60).
Three methods of measuring change were used to analyze the results—a standard pretest/post-test comparison, a patient perceived change rating method, and a perceived
change adjusted for recall bias. The comparison identified a difference between the
methods. With 83.2% of the individuals reporting a clinically significant discrepancy
between the direct comparison and perceived scores, the authors concluded inaccurate
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representation of change in patient self-reported health states could result in unsupported
conclusions. In the evaluation of a pulmonary rehabilitation and self-management
program for chronic obstructive pulmonary disease (COPD) patients, Ahmed, Bourbeau,
Maltais, and Mansour (2009) identified response shift between baseline and 12 months
with one statistical method but not with a second. The unadjusted model underestimated
average change in physical health though the effect was small. Ahmed et al. found that
even small response shift biases could impact effect size—moving the results from small
to moderate or moderate to large. The researchers concluded that response shift should be
identified and accounted for before study results could be accurately interpreted.
Schwartz, Feinberg, Jilinskaia, and Applegate (1999) examined response shift in
young cancer survivors who participated in a 3-day training program. Using an age
matched cohort of healthy subjects, a comparison of pre-test to post-test collected
immediately after the training and 3 months later, suggested that there was an immediate
gain in QoL with a significant decline at the 3-month follow-up. The analysis supported
the hypothesis that the results were influenced by response shift. Adjusting for the shift,
the researchers found that the intervention changes the survivor’s concept of QoL so that
it more closely matched the healthy controls. In behavior modification research, the
identification of response shift has been mixed. Most studies indicated some level of
response shift, with one study reporting both response shift and no response shift
depending on the measurement tool (Ahmed, Bourbeau, Maltais, and Mansour, 2009).
While effect size was not specifically measured in these studies, in Schwartz et al., when
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response shift was considered, the impact of the intervention was adapted from negative
to positive.
The management of chronic conditions is another area where response shift has
been researched. Nolte, Elsworth, Sinclair, and Osborne (2009) explored response shift in
a group-based chronic disease self-management program population. Specifically, the
researchers used measurement invariance tests to compared pre-test to post-test and
retrospective rating to post-test data. QoL was measured at the start of the course and at
the end of the course, typically 6 weeks. The researchers concluded that response shift
was indicated in the retrospective rating to post-test data and not in the pre-test to posttest data. This was contrary to the study hypothesis and to response shift theory. Nolte et
al. concluded that using a pre-test to post-test comparison was appropriate for assessing
the change in this population over 6 weeks and that response shift need not be considered.
Yardley and Dibb (2007) identified response shift in a subpopulation of subjects
with Meniere’s disease, a moderately disabling chronic illness, by analyzing QoL data
measured 10 months apart. The subpopulation with severe symptoms demonstrated
response shift while patients with moderate symptoms did not. An individual’s social
comparison results predicted greater response shift and longer time since diagnosis,
higher self-esteem, and increased optimism were associated with less response shift in
this population. Osborne et al. (2006) identified response shift in an arthritis chronic
disease management program population and developed a paper-based questionnaire to
measure response shift. Using individualized interviews as the gold standard and QoL
input from 2 to 10 months post course for 121 participants, the researchers validated the
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measurement instrument and identified that response shift occurred in approximately
50% of the replies. Of these respondents, 30% realized during the course they had scored
their original QoL too high, negative response shift, and 20% realized they had scored
their original QoL too low, positive response shift. Both Yardley and Dibb and Osborne
et al. concluded that response shift could confound pre-test to post-test assessments and
potentially obscure true treatment effects.
In an investigation of traumatic brain injury, Blair, Wilson, Gouick, and
Gentleman (2010) identified that, contrary to expectations, there was no significant
difference between current and retrospective judgment of past QoL. Researchers asked
subjects directly about their change in QoL. Individual differences in responses existed
with some subjects reporting that prior to their injury, QoL was better and some that their
QoL was worse. When analyzed based on current disability status, a majority of subjects
who were not disabled reported no change in their QoL before and after the injury. On
the other hand, patients who were disabled reported changes in their QoL with
approximately 60% reporting lower QoL while 40% reported increased QoL. Blair et al.
identified response shift as the most likely reason for the change in QoL reported. In the
area of disabled patients, Schwartz et al. (2007) identified that most QoL measures equate
function with health resulting in lower QoL in patients with disabilities regardless of their
individual perception of health.
In chronic diseases, the effect of response shift has been mixed. The phenomenon
was identified in three studies that investigated longer timeframes, though in one study
only a specific subpopulation demonstrated measureable response shift. In a study that
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measured response after 6 weeks, no response shift was identified. Details of effect size
were not specifically evaluated or reported for these studies.
Disease and Condition Research
Response shift has also been researched in a variety of specific diseases and
conditions including cancer (Bernhard et al., 1999; Hamidou et al., 2011; KingKallimanis et al., 2009, Kvam et al., 2010), stroke (Ahmed et al., 2005; Barclay-Goddard,
Epstein, et al., 2009; Mayo et al., 2008) and multiple sclerosis (Schwartz et al., 2011).
While most studies focused on determining the existence of response shift, some also
specifically investigated effect size, recalibration, reprioritization, and
reconceptualization.
As cancer studies often include QoL instruments, several cancer studies have been
used to investigate response shift. In a research overview, Hamidou, Dabakuyo, and
Bonnetain (2011) identified ten clinical trials published between 1999 and 2010 that
illustrated response shift and covered cancer populations with colon, prostate, breast and
multiple myeloma. Methods of treatment including surgery and chemotherapy were
highlighted as potential catalysts to the phenomenon. The review examined response shift
measurement techniques and found that 80% of the trials incorporated the then-test, a
technique that explored response shift by having respondents assess their current and
retrospective QoL at each follow-up. In a colon cancer study, Bernhard et al. (1999)
identified that patients reframed their perception of QoL but that that side effects of
chemotherapy did not induce greater response shift. Patients assessed QoL before
surgery, after surgery, and after randomized follow-up therapies using retrospective
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ratings. Bernhard et al. found that despite the negative impact of chemotherapy, change in
subject perceptions was not significantly impacted by treatment and that adjusting for
response shift diluted the treatment effect but amplified overall improvement in most
QoL indicators.
King-Kallimanis et al. (2009) identified response shift using a measurement
perspective but no response shift in an explanation view in newly diagnosed lung,
pancreatic, esophageal, and cervical cancer patients who were scheduled for surgery.
Using a QoL questionnaire completed prior to and 3 months after surgery, patients
changed the way they conceptualized bodily pain and general health after surgery. The
researchers noted that the general health construct, derived from questions that were
general in nature, seemed to be vulnerable to bias. Using explanation bias guidelines,
optimism and upward comparison variables impacted reported mental well-being,
however because the effect was consistent across the measurement timepoints, this bias
was not interpreted as response shift. In a multiple myeloma population, Kvam et al.
(2010) examined minimally important clinical difference estimates and identified
response shift changes in both magnitude and direction. At baseline and 3 months, 239
subjects who self-identified as either improved or deteriorated, completed QoL
questionnaires. The results of the two groups were compared and researchers found pain,
fatigue, and physical function were retrospectively perceived by deteriorating subjects as
higher at baseline—subjects minimized their prior QoL. On the other hand, improving
subjects had no significant changes in their responses and the authors concluded that for
this group the results were robust with no requirement to account for response shift.

39
Adjusting the deteriorating subject group for response shift would have increased the
resulting change in QoL results between baseline and 3 months by 12 points. These
findings were consistent with other research comparing improving and deteriorating
subjects and identified that response shift may impact study subpopulations differently.
Though the effect may be concentrated in specific subpopulations, response shift has
often been identified in cancer studies. Surgery and longer follow-up timepoints seem to
be associated with identification of this phenomenon.
Stroke populations have also been investigated for response shift. Mayo et al.
(2008) identified response shift in a third of the subjects using data from a longitudinal
stroke study of 387 subjects that collected data at 1, 3, 6, and 12 months post-stroke. The
study, which compared response shift methodologies, found that 67% of the subjects
showed no response shift, 15% negative response shift (expected a higher functional level
than immediately post-stroke), and 13% had a positive response shift (adapted to a lower
normal functional level). Based on validation against retrospective ratings and simulation
analysis, the authors concluded that ignoring response shift could yield an acceptable
model over 12 months post-stroke. Because the methodology used was group based, the
subgroups that experienced response shift would need to be large and in the same
direction to be identified. Because the goal of post-stroke rehabilitation was to provide
subjects with the coping tools to regain their wellbeing, Mayo et al. noted that identifying
that 80% of the population either experienced no response shift or raised their criteria for
QoL could be a negative finding since patients were not adjusting to their new health
status and limitations.
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Using data from a post-stroke study that investigated the effectiveness of at-home
treatments, Ahmed et al. (2005) found conflicting response shift estimates when
comparing three response shift methodologies—SEM, retrospective ratings, and
individualized tests. Based on the retrospective rating and individualized tests, response
shift was identified. The SEM method did not identify response shift. On the other hand,
Barclay-Goddard, Lix, et al. (2009) used SEM to identify response shift at both 6 and 12
months using data from stroke patients. Focusing on the mental health components of
QoL, data from 677 participants who completed five QoL questionnaires at 1, 3, 6, and
12 months post-stoke was analyzed. The researchers identified that this population
demonstrated response shift in one aspect of the scale at 6 months and five aspects of the
same scale at 12 months. Barclay-Goddard, Lix et al. concluded that recalibration
response shift occurred, however effect size was not estimated. These results indicate that
clinical significance and effect size of response shift in stroke populations has been
varied.
Response shift has also been assessed in multiple sclerosis and other medical
conditions. Schwartz et al. (2011) used outcome data from multiple sclerosis patients to
investigate and compare three statistics-based response shift quantification techniques—
SEM, latent trajectory analysis, and recursive partitioning analysis. Data from 3,008
subjects in the North American Research Committee on Multiple Sclerosis (NARCOMS)
data set were classified as relapsing, stable, and progressive without relapse based on the
last 2 years of data and current thinking on disease progression. The authors concluded
that the detection of response shift was dependent on the technique used. Researchers
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using recursive partitioning identified all three aspects of response shift, SEM researchers
identified only recalibration, and those using latent trajectory analysis concluded that
99% of the population did not experience response shift. In general, the research found
little evidence of response shift in the multiple sclerosis population. The limited response
shift findings were unexpected since this population was selected for this research
because as a chronic and progressive neurological disease, it was considered likely to
include response shift. Schwartz et al. highlighted that these null findings could reflect a
true absence of response shift or could be a limitation in the research design or methods.
Research by Li and Rapkin (2009) supported the existence of response shift in an
HIV population. A qualitative evaluation of HIV choices in care study provided insights
into response shift through an assessment between baseline and 6 months of individual
appraisal characteristics (Rapkin & Schwartz, 2004). The researchers identified nine
subgroups of respondents that provided insight into cognitive assessment and response
shift. King-Kallimanis et al. (2010) also investigated the measurement of response shift
using data from HIV/AIDS patient QoL data. Using questionnaires completed every 6
months for 2 years, the authors identified four examples of measurement bias
representing three findings of response shift. However, the researchers could not identify
any theoretical justification or explanation for these findings so concluded these findings
could represent chance results. King-Kallimanis et al. noted that the data did not include a
catalyst event, required by current response shift theory, and that could impact response
shift.
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In a medical device study, Ring et al. (2005) did identify response shift that
impacted treatment effect. In this investigation, the researchers compared implanted
versus conventional dentures using baseline and 3-month follow-ups measured by two
response shift methodologies. The researchers identified both reconceptualization and
reprioritization response shift and found that with traditional analysis no treatment effect
was demonstrated while adjusting for response shift identified a significant treatment
effect.
A significant number of investigations into a variety of health care conditions
have been conducted. Researchers have identified a wide variety of findings with followup timing and measurement technique seeming to impact the results. However, while
literature provides sufficient evidence to indicate that response shift occurs, no consensus
has been reached on the impact of the phenomenon on clinical trials data interpretation.
Spine Research and Response Shift
Spine and orthopedic conditions present a unique population for response shift
research because no biologic or radiographic markers have been found to effectively
assess the result of spine treatment (Don & Carragee, 2008). Therefore the primary, and
often only, goal of treatment is the reduction of pain and improvement of QoL with spine
clinical investigators using function and QoL questionnaires as primary research
endpoints (Copay et al., 2010). Standard practice has been for investigators to compare
patient-reported function and QoL before and after an intervention and provide several
years of QoL follow-up to comply with FDA requirements. Based on a clinically relevant
threshold value, an intervention was interpreted as successful if the level is met.
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Measuring QoL in spine trials may be complicated. First, it is often not possible to blind
patients to their treatment. In particular, medical device trials must address the ethics and
subject expectations when one arm of the study involves surgery and the other
conservative therapy. Additionally, subjects may be provided with new information and
strategies for coping with the consequences of their degenerative condition when followup covers longer periods of time. Finally, as an elderly population, the comorbidities of
aging may also impact perceptions. Adaptation of a patient’s QoL reference standards for
any of these reasons may complicate the interpretation by eliciting response shift.
Researchers have identified paradoxical results that suggest response shift may need to be
considered in spine clinical trial interpretation (Anderson & Gerbing, 1988; Copay et al.,
2010).
Spine Research
Common in North America, chronic low back pain is becoming an increased
burden on the health care system (Don & Carragee, 2008). However, despite its
prevalence, and probably as a result of the complexity of the condition, there are no
standard clinical practice guidelines for surgical intervention. Researchers have evaluated
a wide variety of measurement instruments including condition-specific, disease-specific,
and general health-related QoL tools. To identify the most effective instruments, Walsh,
Hanscom, Lurie and Weinstein (2003) analyzed ODI, Musculoskeletal Outcomes Data
Evaluation and Management System (MODEMS), and short form general health survey
(SF-36) results completed at baseline and 3 months. After classifying subjects as
improved, worsening, and no change and using receiver operating characteristic (ROC)
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curve analysis, the researchers concluded that pain scales have been more responsive than
function scales and there was no significant difference between condition-specific and
general health scales. Therefore, the general SF-36 may be sufficient for low back pain
studies and there was no requirement for condition-specific instruments. Copay et al.
(2008) investigated minimum clinically important change in this population and validated
minimum detectable change for the ODI as 12.8 points, for the physical component score
(a subscale of the SF-36) as 4.9 points, for VAS back pain as 1.2 points and for VAS leg
pain as 1.6 points.
Spine researchers have reported inconsistencies in their research. When
comparing multiple instruments in the same spine population, Copay et al. (2010) found
subjects showed considerable inconsistency with 60% reporting conflicting results
between ODI, SF-36, back pain VAS, and leg pain VAS collected at baseline and 1 year.
However based on an overall change index, the subjects’ opinions on their treatment were
strongly correlated and the authors concluded that the inconsistencies did not invalidate
the QoL measurements. Copay et al. hypothesized that the threshold of tolerable pain
could be translated into meaningful information and noted that the inconsistency between
QoL instrument results should be taken into account when outcomes were evaluated and
clinical relevance assessed. Haro et al. (2008) compared objective measures and QoL
instrument results in spine surgery patients at baseline and 24-months post-surgery. The
objective measures correlated with the leg pain VAS but not with the back pain VAS or
ODI. The SF-36 indicated significant postoperative improvement, in both physical and
mental component summaries. However, the objective measures were significantly lower
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than the mental health subscale and significantly higher than the physical health subscale.
Noting that VAS scores assessed physical health better than mental health and that ODI
was most indicative of a patient’s symptoms, the authors concluded that patient
subjective assessments were important in the evaluation of treatments that focused on the
improvement of QoL.
Researchers and theorists have identified response shift as a potential explanation.
Using a case study, Schwartz and Finkelstein (2009) outlined basic response shift
concepts and applied them to spine research including an assessment of disease trajectory
where the treatment resulted in a partial and not a total cure. In spine conditions,
resolving one set of symptoms may unmask other pre-existing symptoms, for example
the resolution of leg pain exposes back pain. Overestimation of baseline disability may
have no clinical significance when a total cure has been realized; however with only a
partial cure bias in the baseline may impact measured treatment effect. Anderson,
Carreon, and Glassman (2009) also identified incomplete recovery and progressive
degeneration as factors in spine conditions that could impact subject satisfaction and
cause them to underestimate the effectiveness of an intervention. Finkelstein et al. (2009)
also highlighted the potential impact of a partial cure in commentary on orthopedic
surgery results. With one group underestimating their baseline measure of impairment
and the other overestimating this same baseline, the authors identified two directions of
response shift recalibration. Finally, in a study of total knee replacement, Razmjou et al.
(2009) directly investigated the existence, direction, and effect of response shift at 6
months and 12 months postintervention. Using both disease specific and general QoL
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instruments, the researchers identified response shift at both timepoints with an increase
identified from 6 to 12 months. The change was particularly pronounced in the mental
component of the SF-36 QoL results. Traditional analysis did not indicate any
improvement in mental state as a result of the treatment at either timepoint. However, the
values adjusted for response shift demonstrated a statistically significant difference at 12
months.
ISISS Study
The ISISS study is a U.S. investigational device exemption (IDE) pivotal study
that used a prospective, randomized, multicenter trial design to compare the safety and
efficacy of a minimally invasive spine implant in the treatment of lumbar spinal stenosis
(Loguidice et al., 2011; VertiFlex, 2013). Lumbar spinal stenosis is a progressive
degenerative spine condition that is experienced by the patient as low back pain with leg
pain and weakness during standing and walking. These symptoms result in impaired
mobility, limitations in daily activities, loss of independence, and reduced QoL. As a
degenerative disease, lumbar spinal stenosis symptoms can be treated both medically and
surgically but cannot be cured. Therefore, the primary goal of treatment is to maximize
function and maintain QoL.
Subjects at least 45 years old who had experienced a minimum of 6 months of
moderate spinal stenosis symptoms and were unresponsive to conservative care were
enrolled into the ISISS study (VertiFlex, 2013). After signing an informed consent,
subjects were randomized (1:1) to either the investigational or the control device. The
device was implanted and subjects were scheduled for follow-up visits approximately
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every 6 months for a period of at least 24 months. At follow-up visits, subjects were
assessed for neurological function and adverse events, had radiographic imaging, and
completed QoL and function questionnaires including the ZCQ, ODI, SF-12, and VAS
for back and leg pain. The primary endpoint was success at 24 month based on clinically
significant patient improvement as determined by the ZCQ and if postintervention
treatment was required. Secondary endpoints are improvement denoted by satisfaction
score, ODI, VAS, and general health status. Data quality was supported by electronic
case report forms with built-in error checks and regular site and data monitoring in
accordance with good clinical practice and FDA regulations. The ISISS study was
approved by Western IRB (central) or local site IRBs and all subjects provided informed
consent for their data to be used for research purposes. Western IRB determined that the
dataset provided for this analysis met all the criteria for a deidentified dataset and that no
additional approval from the subjects was required for this secondary analysis.
Measuring Response Shift
In discipline overview articles, Schwartz and Sprangers (1999) and BarclayGoddard, Epstein, et al. (2009) identified a wide variety of methods that had been
implemented to investigate response shift. The methodologies can be grouped into
prospective approaches, where response shift assessment is incorporated into the research
design, and statistical approaches, that can be implemented as a secondary analysis.
Prospective approaches include retrospective ratings, individualized methods, and
preference-based methods. Statistical approaches include ANOVA analysis, growth
curves interpretation, latent trajectory analysis, and SEM. An overview and assessment of
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these methods will be presented. Due to the early stage of response shift development,
not all methods have the same level of implementation or empirical evidence.
Retrospective Ratings
One of the first and most commonly applied design approaches for assessing
response shift has been retrospective ratings, commonly called the then-test (BarclayGoddard, Epstein, et al., 2009; Schwartz & Sprangers, 1999). In this method, subjects
complete the QoL instrument at baseline (the pre-test) and at follow-up (the post-test). In
addition, at follow-up the respondent provides a retrospective assessment of their baseline
QoL, the then-test. This method has been based on the concept that since the posttreatment QoL and reassessed baseline QoL would be completed at the same time, the
respondent would be using the same QoL internal standards, values, and concepts. A
comparison of the post-test and then-test would minimize any bias and indicate
unconfounded treatment effect. The difference between the baseline (the pre-test) and the
retrospective score (the then-test) indicate the level and direction of response shift,
specifically recalibration (Ahmed et al., 2005; Schwartz et al, 2005, Schwartz &
Sprangers, 1999). The then-test methodology was initially developed to assess
educational training programs but has been adapted to be used in health care (Schwartz &
Sprangers, 1999).
Health care researchers in a number of medical conditions have used the then-test
to explore response shift including studies of cancer (Hamidou et al., 2011; Jansen,
Stiggelbout, Nooij, Noordijk, & Kievit, 2000; Kvam et al., 2010; Schwartz, Feinberg,
Jilinskaia, and Applegate,1999; Visser, Oort & Sprangers, 2005), stroke (Ahmed et al.,
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2005, chronic disease (Yardley and Dibb, 2007), orthopedics (Razmjou et al., 2009), and
dental implants (Ring et al., 2005). The researchers documented that retrospective ratings
were relatively easy to administer and to interpret. The reliability of the then-test
approach is similar to the original measurement tool so most instruments with strong
psychometric properties can be used (Schwartz & Sprangers, 1999). The body of
literature supports the value and usefulness of integrating then-tests into response shift
research.
Despite extensive usage, researchers have also identified potential concerns with
the then-test. As patients may not be able to accurately recall their health from months
earlier and so incorrectly report prior health, investigators have been concerned that this
technique may identify both recall bias and response shift. In an investigation of patient
care facilities, McPhail and Haines (2010b) identified a clinically meaningful change
between longitudinal results and patient retrospective results in 83.2% of the subjects.
However, when the data was adjusted for recall bias, the change was reduced to 7.9%.
Based on a review of studies, Barclay-Goddard, Epstein, et al. (2009) identified that how
the individual considers the renewed judgment of prior health can impact the findings. If
the respondent recalls their prior health state and answers based on that information, the
then-test would be accurate. However, if the respondent internally calculates prior health
based on perceived change, as predicted by implicit theories of change, the result may be
biased. Adding to the mixed results, Nolte et al. (2009) tested the psychometric
performance of the then-test in chronic disease management and concluded that while the
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standard pre-test/post-test was robust, the performance of the then-test/post-test could be
influenced by implicit theory of change, social desirability, and recall bias.
Other considerations when using the then-test include the requirement for subjects
to complete multiple questionnaires and for the additional instruments to be incorporated
into initial study design (Barclay-Goddard, Epstein, et al., 2009). Finally, the tested
population is also required to meet minimum cognitive and memory ability requirements
(Ahmed et al., 2005; Schwartz & Sprangers, 1999). Based on these concerns, Reeve
concluded in a 2010 commentary on response shift that QoL researchers agreed that
better methodologies than the then-test existed for the assessment of response shift.
Individualized Approaches
Individualized methods are measurement techniques that enable the respondent to
define and assess the aspects of QoL that are the most relevant to them by integrating
subject feedback with specific QoL factors. Instruments, such as the Schedule for the
Evaluation of Individual Quality of Life (SEIQoL) and Patient Generated Index (PGI) are
most often formatted as semi-structured interviews where the subject selects their five
most relevant QoL domains and scores them (Schwartz & Sprangers, 1999). Subjects
may identify the domains on their own or select from a reference list. After treatment or
over time, the subjects reaccomplish the assessment. Hamidou et al. (2011) highlighted
that using these tools researchers could generate an overall index, document the relative
importance of each domain at each timepoint, and identify changes in relevant domains
over timepoints.
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Used by researchers to evaluate response shift in a range of health care situations
including cancer (Hamidou et al., 2011), head injury (Ahmed et al., 2005; Blair, Wilson,
Gouick, and Gentleman, 2010), comparison of treatment (Ring et al., 2005), and disease
self-management (Osborne et al., 2006), the primary advantage of individualized
approaches is the focus on the unique, individualized construct of QoL perception. Each
participant can identify the aspects of QoL that are relevant to them at the time of the
assessment. By comparing changes in domains and weights, researchers can identify
specific differences over time and explore more about the meaning of the response shift
(Barclay-Goddard, Epstein, et al., 2009; Schwartz et al., 2005). However, the complexity
of the individualized assessments may restrict the populations that can be tested since
subjects need to have significant cognitive ability to be able to provide relevant input
(Blair et al., 2010). Additional disadvantages of this methodology include converting
results into numerical values can be difficult (Barclay-Goddard, Epstein, et al., 2009),
effective comparison can be challenging since context is changing (Schwartz &
Sprangers, 1999), and the time-consuming interview requirement can make the approach
impractical for larger studies and some disease states ( Hamidou et al., 2011).
Preference-Based Methods
Related to individualized approaches, preference-based methods of assessing
response shift ask respondents to rate the value of specific health states such as the
acceptable tradeoffs between longevity and a specific health aspect. This approach
includes the Q-Twist method, preference mapping, and the ideal scale approach
(Hamidou et al., 2011; Schwartz & Sprangers, 1999). In the ideal scale approach, patients
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are asked to report both their current and ideal QoL on the same scale. Hamidou et al.
(2011) noted that when repeated at different timepoints, researchers could compare the
ideal results and identify recalibration and reprioritization response shift.
Preference-based approaches have been used to evaluate response shift in cancer
(Hamidou et al., 2011; Visser et al., 2005) and AIDS/ HIV patients (Schwartz et al.,
2005). However, while labeled a promising approach in 1999 (Schwartz & Sprangers),
only a small number of researchers have used preference-based techniques to investigate
response shift in current health care literature. Ease of implementation and resistance to
recall bias are advantages of preference-based approaches (Schwartz et al., 2005).
However, difficulties of this methodology include the potential for ceiling effects that
may limit the results and interpretation may be complicated since both recalibration and
reconceptualization are integrated into a single construct (Hamidou et al., 2011).
Implementation also often requires advanced statistical techniques (Schwartz &
Sprangers, 1999). This approach can also be time intensive for both participants and
clinical investigators.
Statistical Approaches
Statistical approaches are the final general methodological classification used by
researchers to evaluate response shift. These techniques use statistical tools to identify
trends in research data. Statistical techniques have been as simple as paired t-tests
(McPhail & Haines, 2010b) and as advanced as SEM (Barclay-Goddard, Epstein, et al.,
2009). Additional statistical techniques have included growth curves, regression trees,
and latent trajectory analysis. Growth curves techniques have been used to compute and
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compare individual slopes on variables of interest. The flexibility of this method and
ability to assess relationships between two or more curves enabled growth curves to
support complex problems (Barclay-Goddard, Epstein, et al., 2009; Schwartz &
Sprangers, 1999). Regression tree analysis used repeated classification techniques to
divide the research population into subpopulations that were more homogenous (Li &
Rapkin, 2009). These subgroups enabled researchers to gain increased insight into
response shift. Latent trajectory analysis created a predictive General Health model and
examined discordances between predicted and observed results (Mayo et al., 2008).
Statistical approaches have been used by researchers to evaluate response shift in
a variety of medical conditions including cancer (King-Kallimanis et al., 2009; KingKallimanis et al., 2012; Oort et al., 2005; Visser et al., 2005), stroke (Ahmed et al., 2005;
Barclay-Goddard, Lix, et al., 2009), multiple sclerosis (Schwartz et al., 2011), COPD
(Ahmed et al., 2009), and HIV/AIDS (Li & Rapkin, 2009). Being model based has
provided statistical approaches with a key benefit since it allowed researchers to test
multiple response shift hypotheses at the same time (Schwartz & Sprangers, 1999). Data
collection and research design were also simplified as only data from standard QoL
instruments already included in the study were required. The ability to perform response
shift analysis after the data has been collected, as secondary research, provides another
significant benefit since comparative clinical trials that did not originally incorporate
response shift assessment may investigate this phenomenon. The disadvantages of
statistical approaches include results that may not be easily interpretable for nonstatisticians (Schwartz & Sprangers, 1999) and the potential for the components of
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response shift to be integrated in a way that makes disentangling the results difficult
(Mayo et al., 2008). Additionally, statistical techniques, such as SEM, often require fairly
significant samples sizes (Kline, 2011) and the required focus on group-level results may
mask important individual or subgroup effects (Barclay-Goddard, Epstein, et al., 2009).
In investigating response shift, researchers have proposed and implemented a
number of measurement techniques. However no single technique has become standard
for the discipline. As with all research, the specific research problem should direct the
methodology. Since response shift assessment has not been incorporated into most health
care clinical trials, to best support the response shift integration into practice a technique
that can be performed as a secondary analysis of existing data would be preferred. SEM,
a statistical approach, meets that criterion.
SEM
Based on the exploration of the structure of means, variances, and covariances of
variables of interest, health care researchers have used a statistical modeling technique,
SEM, to explore response shift. This family of related multivariate analysis procedures
includes path analysis, confirmatory factor analysis, and structural regression (Kline,
2011). SEM enables researchers to study and test complex linear relationships between
both observed and latent (unobserved) variables and allows variables to be indicated by
multiple measures. Primarily a confirmatory technique, the SEM process involves a
researcher hypothesizing the causal model, depicting it as a path diagram, and then
testing the model using empirical data. The flexibility of specifications and requirement
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for theoretical justification enable SEM to be used to effectively to address and model the
complexity of health care and response shift.
SEM Overview
SEM is a collection of multivariate analysis procedures that focus on means,
variances, and covariances to explore relationships between observed and latent
(unobserved) variables. Confirmatory factor analysis, a SEM model, is used to determine
if collected data fit a theory-based measurement model. Based on covariance, the
procedure is designed to accomplish two goals—to understand the patterns of covariance
and to use the researcher-specified model to explain as much of the variation as possible
(Kline, 2011). The variables that can be included in a structural equation model support
the complexity of social science research. Variables may be observed or unobserved
(latent) with some of the latent variables representing measurement error. The scale of a
latent variable is arbitrary and must be set in the model by the researcher. By setting the
variance of a latent variable to 1, the scale can be standardized. Alternatively, the variable
may take on the scale of one of its indicator variables (Lei & Wu, 2007). These
conventions allow for model simplification since when fixed in either manner, the
variables are not estimated from the data. Similarly, since for endogenous variables all
effects are included in the model, no unanalyzed associations occur between these
variables (Kline, 2011).
Kline (2011) identified six steps typical of SEM—specify the model, confirm
model identification, select measures and collect data, estimate the model, respecify the
model, and report the results. In the first step of the process, researchers create a
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hypothesis of the relationships of interest and their interconnections based on literature,
observations, and logical reasoning. A good model should be theoretically justifiable,
simple and straightforward, and reproduce the correlation matrix based on the constraints.
In the identification step, the researcher verifies that it is theoretically possible for a
computer to derive a unique estimate for every model parameter. The third step of this
technique is to collect the data and prepare the dataset. Preparation and screening of the
data will ensure that if no SEM solution is produced, the null result is a function of an
invalid model and not data issues. With the data available and verified, the researcher
uses a SEM computer tool to conduct the analysis. This step, called estimation, includes
evaluating model fit, interpreting the parameter estimates, and considering equivalent
(and near-equivalent) models. The chi-square test can be used to test the null hypothesis;
however, this test is sensitive to sample size and may reject a reasonable data fit based on
a large number of samples (Lei & Wu, 2007). Alternative goodness-of-fit indices have
been created to adjust for this effect and SEM experts recommend that multiple indices
be considered when overall model fit is being evaluated (Kline, 2011; Lei & Wu, 2007).
The fifth step in the SEM process is respecification, the reworking of the model to
address any issues identified in earlier steps (Kline, 2011). A key consideration of
respecification is that changes should be guided by rational considerations and Kline
recommended that researchers identify theoretically justifiable changes in the original
Step 1 model specification. The final step in the SEM research is to document the
analysis completely and accurately. Building on the earlier steps of the SEM process,
reported results should include a comprehensive review of the specification of the model,
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documented validation of identification, complete characterization of the sample data,
listing of SEM program and assumptions, review of the estimation, and discussion of any
respecification required. Confirmation bias should be addressed and the implications of
the analysis, whether the model was retained or not, should be highlighted.
Due to its focus on covariance and since standard error may not be accurate with
small samples, SEM is a large sample technique. This requirement can have significant
impact on the research questions that can be addressed. Because SEM can produce both
simpler and more complex models, there is no universal guideline for sample size.
Researchers have proposed that the ratio of cases to the number of model parameters be
set at between 10 and 20:1 (Kline, 2011). However in practice the typical sample size for
SEM studies is about 200 cases, the approximate median sample size of peer-reviewed
articles published in psychology and management science journals that used SEM
techniques. The flexibility available from SEM can provide researchers with an excellent
tool for understanding complex social situations including response shift. A number of
QoL researchers including Hamidou et al. (2011), Oort (2005b), and Schwartz et al.
(2011) identified SEM as the most pragmatic method of integrating response shift into
clinical practice since it addresses multiple variables simultaneously and it does not
increase effort or time commitment from the subject or clinical investigator during data
collection.
SEM for Response Shift
While a variety of factor analysis and covariance methods have been proposed,
the use of SEM has emerged as a promising response shift assessment technique. Two
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methods have been demonstrated in the literature, the Schmitt method and the Oort
method. While both SEM, there are differences in both the theory and methodology. The
Schmitt method begins with an unconstrained model and adds constraints, retaining only
those constraints that work. Conversely, the Oort method begins with a fully constrained
model and releases constraints that are untenable. Ahmed et al. (2009) directly compared
the Schmitt and Oort SEM techniques in a COPD population that participated in a selfmanagement program. Using two QoL instruments and data from baseline and 1 year, the
Schmitt method did not identify any response shift while the Oort method found
significant changes. The authors concluded that these subjects did experience response
shift that underestimated change in physical health and that the Oort procedure was more
sensitive in detecting response shift than the Schmitt method.
The body of work to support the Oort SEM methodology for response shift
assessment includes publications that address the theory, application of the SEM
technique to clinical data, and mathematical correlations to recalibration, reprioritization,
and reconceptualization (Oort, 2005a; Oort, 2005b; Oort et al., 2005). Ahmed et al.
(2005) investigated response shift in a post-stroke population at 6 months, comparing
three techniques—SEM, the then-test, and an individualized approach. The results were
mixed with the then-test and individualized approach identifying response shift and the
SEM not showing any response shift. Visser et al. (2005) also compared three methods of
assessing response shift in a cancer study with QoL collected at baseline and 3 months
post-surgery. The methods included the then-test, a preference-based approach, and SEM.
In the study, all three methods identified response shift with the then-test and SEM
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results largely comparable. The preference-based approach also identified response shift
but in different domains and in a divergent direction. The authors concluded that due to
the limitations of the preference-based test, the time required and the qualitative nature of
the data, the then-test and SEM approaches were preferred for future research.
King-Kallimanis et al. (2009) explored the difference in measurement and
conceptual perspectives of response shift by applying SEM to a cancer population
undergoing surgery. Five measurement response shift biases were identified but no
explanation response shifts were identified. This application successfully added the
exogenous factors of cancer site, health status, sex, age, optimism, and social comparison
to the SEM methodology. In a further expansion of the Oort method, Barclay-Goddard,
Lix, et al. (2009) evaluated response shift over multiple occasions in a post-stroke
population. Response shift was identified at both 6 and 12 months though the shifts were
not identical at these timepoints. The authors validated the SEM modeling technique for
response shift and illustrated the usefulness of the information. Schwartz et al. (2011)
compared three statistical methods for evaluating response shift, including SEM. Only
small response shift effect sizes were identified in the multiple sclerosis population by all
methods. However, the research did support the operationalization, interpretability, and
data usage of the techniques. While based on the range of results a definitive best method
could not be selected, in the comparison SEM yielded the clearest findings, effectively
compared disease-specific to generic outcomes, and was determined to be the most
successful.
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When applied to response shift and health care research, SEM strengths include
the ability to incorporate multiple variables into the model, the inclusion of measurement
error, and the fact that this technique can be applied without additional data collection.
Finally, since in the social sciences the magnitude of the effect is often most important
and not the specific result of the statistical test, SEM provides better estimates of effect
size for observed variables than many other mathematical techniques (Kline, 2011). A
detailed methodology for this research study based on the Oort SEM technique is
included in Chapter 3.
Conclusion
The use of patient-reported outcomes to support clinical trials and evidence-based
medicine have highlighted the potential impact response shift phenomenon can have on
study interpretation and conclusions. When individuals report their QoL at different
timepoints, the results may be affected by changes in the individual’s internal standards,
values, or conceptions. This can complicate the evaluation of longitudinal data and result
in under- or overestimation of treatment effects. In this review I have outlined the
theoretical foundation of response shift and presented current research in health care
including the diversity of findings in specific medical conditions and over different
timeframes. Researchers have explored a variety of techniques to identify and quantify
response shift including retrospective rating, individualized approaches, and statistical
methods. While the scholarly literature has explored response shift, the significance in
comparative clinical trials of medical devices has not been extensively studied.
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Investigating the clinical significance in a randomized clinical trial comparing two
spine interventions, a population expected to experience response shift, would support the
translation of response shift research into practical guidance for investigators and clinical
trial designers. By using SEM, a statistical method sensitive to all components of
response shift and appropriate for secondary analysis, any differences in response shift
impact on the control and test groups at different timepoints could be explored. A
practical application of response shift assessment would support clinical investigators,
health care professionals, and QoL researchers in determining if response shift analysis
should be incorporated into comparative trials using patient-reported outcomes. Chapter 3
contains the specifics of the study design, clinical data, and modeling techniques to
investigate response shift in the ISISS spine intervention study (VertiFlex, 2013).
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Chapter 3: Research Method
In spine interventions, clinical investigators typically compare subject-reported
QoL scores from pre- and postintervention to document the effectiveness of treatments.
However, subjects can adjust the way they score their QoL based on factors unrelated to
the intervention including changing individual internal standards, values, and
prioritizations. These changes, called response shift, could invalidate direct comparison
of the QoL scores. Using data from a spine intervention trial and applying SEM
techniques, I used a quantitative study design to explore response shift phenomenon and
analyze the potential impact on comparative clinical trial data interpretation. Evaluating
changes in response shift over time and determining if there was a difference in response
shift between treatment groups will provide researchers with insight into the clinical
significance of response shift for this subject population. This chapter contains an outline
of the research design, data preparation, study population, the data analysis plan, and
modeling framework for this research.
Research Design
Using data from a randomized clinical trial comparing the effectiveness of two
medical devices and SEM, I explored response shift through 12 months using a
longitudinal confirmatory modeling research design. Data from four lumbar spinal
stenosis and spine QoL and function questionnaires were used to address the following
research questions:
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1. Do treated back pain patients experience a difference in response shift
between baseline and 3 months and between baseline and 12 months
postintervention?
2. Does response shift phenomenon influence the clinical comparison of patientreported outcomes between baseline and 12 months in a randomized clinical
trial for a spine intervention?
Answering these research questions supported understanding of response shift in a
variety of ways. First, by exploring response shift over time, I provided information about
the existence of response shift and potential catalyst events in a spinal intervention
population. If response shift was not detected, then spine investigators could continue to
implement standard research designs with an increased level of confidence that their
results were not biased by this phenomenon. If response shift could be detected, then
investigators would be aware of this potential bias and could incorporate this knowledge
into their clinical trial data interpretation. I supported the identification of catalyst events
by characterizing differences in response shift between postintervention and later
occasions. By addressing the second research question, I focused on clinical trial
comparisons and response shift. To minimize bias, researchers often prefer study designs
in which subjects are blinded to their treatment. However, in medical device clinical trials
involving surgery, it is often difficult to prevent subjects from knowing which
intervention they received. This knowledge has an unknown impact on expectations and
therefore could influence response shift. Determining if response shift impacted two
treatment groups differently could influence the confidence investigators have in their
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study conclusions. Finally, performing this research using SEM supports the assessment
of the practicality of implementing this methodology for response shift investigation.
The ISISS study, the source of the data, was designed to determine the
equivalence between the control and investigational devices (Treatments A and B) by
comparing the number of successful interventions at 24 months. Researchers defined a
successful intervention based on the improvement in patient-reported outcomes collected
by the ZCQ, ODI, SF-12, and VAS for back, right leg, and left leg pain. Investigators
focused secondary endpoint analysis on comparisons of patient health status pre- and
postintervention using clinical difference thresholds and t tests. However, these statistical
comparative techniques assume that at every timepoint subjects used the same internal
standards, values, and conceptualization to assess their QoL. QoL researchers have
identified that response shift phenomenon may invalidate this assumption but that QoL
instruments are not designed to determine the impact of response shift (Razmjou et al.,
2009; Schwartz et al., 2006; Sprangers & Schwartz, 1999; Wilson, 1999). Therefore, an
alternative analysis technique was required. Through my analysis of the literature, I
identified SEM, an advanced modeling technique, as an effective tool for investigating
the phenomenon and employed it for this research.
Modeling techniques have been used effectively to create theory, to describe
cause-and-effect relationships between variables, and to predict system output based on
inputs. In an alternative application of modeling, Oort et al. (2005) demonstrated that
evaluating variable invariance in a SEM model could detect and provide insights into
response shift. After an appropriate measurement model was developed, constraints were
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added and removed systematically. The fit and equivalence of the resulting models were
evaluated. If the constraints significantly changed the model’s goodness of fit, then
response shift associated with the constrained variables was identified and could be
investigated in more detail.
In this research, I created a theoretically justified structural equation model using
subject-reported QoL responses to validate and optimize the model. As SEM terminology
replaces dependent and independent variables used in other statistical methods with
observed and latent variables, I incorporated these variables in a confirmatory path model
to represent subject QoL reporting. I selected the observed variables from the
questionnaire data provided from the QoL instruments and designated the latent
variables, the unmeasurable true physical and mental states of the respondents, as PQoL
and MQoL. Due to inherent measurement error and the many ways QoL concepts are
interpreted by individuals, latent variables cannot be directly collected by behavior
instruments. When an adequate model was supported, I systematically adjusted the
constraints and analyzed the results using LISREL 9.1 SEM software (Scientific Software
International, 2013). To determine if response shift was present, I evaluated the
invariance of the model, direct effects, and variable responses. In order to address the
research questions, I tested the constraints associated with measurement occasions (3
months, 12 months) and the exogenous variable treatment group (A or B). Further details
of the analysis are outlined in the Data Analysis Plan section.
I selected a statistical approach, SEM, for this research to maximize the
generalizability and value to health care clinical investigators. Other alternatives, such as
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retrospective ratings and individualized approaches, require response shift investigation
to be included in the original study design as an additional input. Because of the added
research complexity and subject burden, few current comparative clinical trials have
incorporated this data collection into their research. Statistical techniques only require
data from QoL instruments used in the primary analysis and so can be effectively used
for secondary analysis. Additionally, SEM addresses both measurement and conceptual
issues in a single model, can identify all three components of response shift, and can
address multiple follow-up timepoints (Hamidou et al., 2011; Oort et al., 2009; Schwartz
et al., 2011). This method has also been demonstrated in the literature (Barclay-Goddard,
Lix et al., 2009; King-Kallimanis et al., 2011, King-Kallimanis et al., 2012; Oort et al,
2005). For these reasons, I identified a SEM technique using data from an on-going spine
intervention study to support this investigation.
Data and Instrumentation
Statistics & Data Corporation (SDC), the ISISS study sponsor’s data manager, at
the direction of the sponsor, VertiFlex, Inc., provided me with the limited dataset in an
Excel format. VertiFlex obtained permissions to use all instruments as part of the ISISS
study including authorization for secondary analysis (Appendix A). As the ISISS study
was designed and conducted to support a premarket application for the FDA, the sponsor
employed quality control techniques to ensure the validity of the data including (a)
electronic case report forms (eCRFs) that included built-in edit checks, (b) on-site
monitoring, and (c) general quality control. Based upon the quality control measures in
place, I accepted the assumption that data accuracy was sufficient to support this
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research. The research dataset was formatted as an Excel file. I will maintain the limited
dataset provided by VertiFlex for audit purposes in compliance with Walden University
policies.
Instruments
Four primary lumbar spinal stenosis and spine QoL and function questionnaires
were used to collect data for the ISISS study—the ZCQ, ODI, SF-12, and VAS for back,
right leg, and left leg pain. Each of these instruments was previously validated in spine
and back conditions. The details of the validations can be found in the literature and are
outlined in the individual instrument descriptions that follow.
ZCQ. The ZCQ is a condition-specific instrument for lumbar spinal stenosis. It is
a self-administered three-section patient survey covering symptom severity, physical
functioning, and patient satisfaction with treatment. Satisfaction with treatment, Part 3, is
only scored after an intervention has been performed. Items are scored with a 5-point
Likert scale for symptom severity and a 4-point Likert scale for physical function and
satisfaction. The results are calculated by subscale and expressed as a percentage of the
maximum possible score with higher scores representing increased disability or
dissatisfaction. As the result for each subscale is expressed as a percentage of the
maximum possible based on questions answered, missing answers have been addressed in
the scoring. Validity, reliability, and predictive ability have been well studied (Pratt,
Fairbank, & Virr, 2002; Stucki, Daltroy, Liang, Fossel, & Katz, 1995; Stucki et al., 1996)
ODI. The ODI is a condition-specific instrument for spine disorders and low
back pain. Composed of 10 items, the self-administered questionnaire is designed to
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evaluate how spine issues, specifically back or leg pain, are impacting the respondent’s
ability to handle everyday life. Items are scored on a 6-point Likert scale with the final
score calculated as a percentage with lower scores representing minimal disability and
higher scores increased disability. As one of the most commonly used outcome measures
in spine issues, validity, reliability, and predictive ability have been well studied
(Fairbank, Couper, Davies & O’Brian, 1980; Fairbank & Prysent, 2000; Pratt et al., 2002;
Walsh et al., 2003).
SF-12. The SF-12 is a multi-purpose health survey that measures functional
health and well-being using 12 questions. Commonly called the SF-12, this instrument
does not target a specific population or disease and measures multiple health domains
including physical and mental components. Respondents report on physical and social
activities that can be accomplished, how often they are performed, and the level of
difficulty associated with them. The SF-12 is an adaption of the longer 36 question SF-36
survey and was designed to be easier and faster for patients to complete. This instrument
is recommended for large studies and for group comparisons; however the more granular
SF-36 is preferred for individual decision-making (Resnik & Dobrzykowski, 2003)
The SF-12 scale includes two primary subscales, a physical composite subscale
(PCS) and a mental composite subscale (MCS), and eight domains. The subscales and
domains are generated by scoring, combining, weighting and normalizing test item
responses. The specific scoring formula is proprietary, however the developer, Quality
Metric, provided the subscale and domain results as part of the licensing agreement. The
scales have a range of 0 – 100 with norms set by the developer based on a mean of 50 and
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standard deviation of 10. Norms therefore vary and are uniquely associated with
population age groups. In the U.S. general population, PCS normal decreases with age
and MCS normal increases with age. The physical score is made up of four individual
domains—Physical Function (PF), Role Physical (RP), Bodily Pain (BP), and General
Health (GH). The mental score is also composed of four domains—Mental Health (MH),
Role Emotional (RE), Social Functioning (SF), and Vitality (VT). The validity and
reliability of the SF-12 subscales and domains have been well established for both
general and low back pain patient populations (Jenkinson et al., 1997; Luo et al., 2003;
Resnik & Dobrzykowski, 2003; Ware, Kosinski & Keller, 1996).
VAS. The VAS is a single item measurement tool for patient pain severity.
Respondents report their pain by marking their pain level on a 100 mm line. No pain is
the anchor at the left extreme and worst pain possible is the scale of the right extreme.
The score is determined by measuring the number of millimeters between the left starting
point and the patient’s mark. Outcomes are between 0 and 100 with higher scores
indicating increased pain. The VAS is the most frequently used pain outcome measure for
back pain and validity and reliability have been demonstrated (Litcher-Kelly, Martino,
Broderick, & Stone, 2007; Moore, Moore, McQuay, & Gavaghan, 1997; Olaogun,
Adedoyin, Ikem & Anifaloba, 2004).
Data Collection and Preparation
I requested a limited dataset containing demographic and QoL information from
the ISISS study at an in-person meeting with Steve Reitzler, Vice-President Regulatory
and Clinical Affairs, VertiFlex, Inc. After input from Western IRB who determined that
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the dataset met all the criteria for a deidentified dataset and that no additional approval
from the subjects was required for secondary analysis, Mr. Reitzler directed the ISISS
data management provider, Statistics & Data Corporation (SDC), to e-mail a dataset to
me for use in my dissertation (Appendix A). To further deidentify the data and ensure no
negative impact on the ISISS study, subject identification codes were converted from a
site-subject format to a subject only format, treatment group was blinded, and only 12month and earlier follow-ups were included in the data.
As of May 2012, 476 subjects had been enrolled in the ISISS study with 288
subjects having received an implant and reached 12 months post device surgery. To
support the structural equation model, only subjects who had data from the 12-month
follow-up were included in the analysis dataset. The data collected in the ISISS study,
provided in the limited dataset, and required for the research dataset are outlined in Table
2.
I created a raw data file limited to all subjects who met the inclusion criteria. I
ensured the variables could be implemented by the LISREL 9.1 software and compared
the source and LISREL datasets to each other to ensure accurate transfer and formatting.
After error checking was complete, I saved the file and made backups. Backups were
stored separately and as part of an offsite backup service (Carbonite, Boston, MA). The
dataset was screened for extreme collinearity, outliers, missing data, and multivariate
normality in accordance with Kline (2011) and LISREL 9.1 program guidelines.
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Table 2
Data Collection for the ISISS Study and Research Data Set

Demographic Info

ISISS Study
Scheduled Data
Collection
Baseline

Randomization

Surgery

Data Collected

Spine X-rays

Neurological status

Baseline, Discharge,
6 weeks, 3, 6, 12,
18 & 24 months
Baseline, Discharge,
6 weeks, 3, 6, 12,
18 & 24 months

Limited Data Set

Research Data
Set

Baseline

Baseline

Surgery

Surgery

-

-

-

-

Adverse events
(hospitalizations,
death)

Baseline, Discharge,
6 weeks, 3, 6, 12,
18 & 24 months

-

-

QoL Instrument –
Patient Satisfaction

6 weeks, 3, 6, 12,
18 & 24 months

-

-

Baseline, 6 weeks,
3, 6 & 12 months
Baseline, 6 weeks,
3, 6 & 12 months
Baseline,
Discharge, 6
weeks, 3, 6 & 12
months
Baseline,
Discharge, 6
weeks, 3, 6 & 12
months

Baseline,
3 & 12 months
Baseline,
3 & 12 months

QoL Instrument - ODI

Baseline, 6 weeks,
3, 6, 12, 18 & 24 months
Baseline, 6 weeks,
3, 6, 12, 18 & 24 months

QoL Instrument - SF12

Baseline, Discharge,
6 weeks, 3, 6, 12,
18 & 24 months

QoL Instrument - VAS

Baseline, Discharge,
6 weeks, 3, 6, 12,
18 & 24 months

QoL Instrument - ZCQ

Baseline,
3 & 12 months

Baseline,
3 & 12 months
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Modeling Dataset
I included the variables listed in Table 3 in the research dataset for use in
assessing and optimizing the SEM model. In accordance with Kline’s (2011)
recommendation that scales be used as source data for SEM and as these outputs would
be more representative of the results used for clinical interpretation, I did not include
individual item responses in the dataset.
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Table 3
Modeling Dataset Variables
Variables
Age

Description
in years at time of surgery

Race
Gender
Vertebral levels
BMI
Treatment group

Occasion
ZCQ part 1 score
ZCQ part 2 score
ZCQ part 3 score
ODI score
PCS
MCS
PF
RP
BP
GH
V
SF
RE
MH
VAS back pain score
VAS leg pain score

1 level or 2 consecutive levels
coded as A or B - investigational device (VertiFlex Superion™) or
control device (X-Stop®). The assignment of code to specific
treatment has been blinded.
Baseline, 3-month follow-up, 12-month follow-up
Symptom severity
Physical function
Satisfaction with treatment - for follow-up intervals only
Physical Component Subscore of SF-12
Mental Component Subscore of SF-12
Physical function domain of SF-12
Role physical domain of SF-12
Bodily pain domain of SF-12
General health domain of SF-12
Vitality domain of SF-12
Social functioning domain of SF-12
Role Emotional domain of SF-12
Mental health domain of SF-12
Right leg and left leg scores added together to create one variable

Note. BMI = Body Mass Index; ZCQ = Zurich Claudication Questionnaire; ODI =
Oswestry Disability Index; SF-12 = Short form general health survey; VAS = Visual
Analog Scale for pain.
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Study Population
This study involved secondary analysis of data collected to support a premarketing approval of a minimally invasive spinal implant, the ISISS study (VertiFlex,
2013). Data were collected from June 2008 through May 2012.
ISISS Population
The ISISS study used a prospective, randomized, multicenter trial design to
compare the safety and efficacy of a minimally invasive spine implant for treatment of
lumbar spinal stenosis (Loguidice et al., 2011; VertiFlex, 2013). As a degenerative
disease, lumbar spinal stenosis symptoms can only be treated but not cured. Therefore,
the primary goal of treatment is to maximize function and maintain QoL. The ISISS
study recruited subjects from 32 sites in the United States. Clinical investigators
identified potential subjects from their patient populations who met study inclusion
criteria of being at least 45 years old, had experienced a minimum of 6 months of
moderate spinal stenosis symptoms, and been unresponsive to other treatments. These
patients were presented with the opportunity to enroll in the ISISS clinical trial
(VertiFlex, 2013). If they agreed and after signing informed consent, subjects were
randomized to either the control or the investigational device groups with half the
subjects assigned to receive the control device (X-Stop®) and half to receive the
investigational device (Superion™). The subjects had the surgery performed and the
device implanted. Subjects returned to the investigator’s sites for follow-up and
completion of QoL questionnaires at regular intervals through 24 months. The data from
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these follow-ups were collected in 21 CFR part 11 compliant data systems that included
electronic case report forms with built-in error checks.
Sample Size
The ISISS study used a non-inferiority hypothesis between the two treatment
groups and a Bayesian adaptive approach for sample size selection with the final number
of subjects enrolled equal to 463. As of May 2012, when the dataset was created, 288
subjects had completed their 12-month follow-up visit. I combined the data into a single
data file suitable for import into LISREL 9.1, a SEM software package.
Kline (2011) instructed that sample size for SEM is dependent on the specifics of
the model so no universal guidelines exist. The number of parameters in the final model,
specific estimation algorithm, and distributional characteristics of the data all impact
required sample size. Researchers have proposed that the ratio of cases to the number of
model parameters be set at between 10:1 and 20:1. In this research, the model used to
assess response shift had a ratio of 18:1 cases to parameters. However, this guidance is a
rule of thumb and cannot be rigorously tested since the details of each model and data
characteristics have a significant impact on power estimates. In practice the typical
sample size for SEM studies published in peer-reviewed literature is about 200 subjects
(Kline, 2011). Using a representative model with parameter numbers similar to the model
used in this research, Oort (2005b) calculated the sample size required to detect
reprioritization change. Reprioritization represented the sample size required for the Oort
SEM analysis as recalibration and reconceptualization have a larger impact on observed
means and covariances and therefore require fewer cases. Oort reported that for a
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statistical power of 80%, a sample size of 170 was required and to increase the power to
90%, a sample size of 228 was sufficient. Therefore, a sample size of 263 complies with
SEM established practice and was adequate to identify SEM tested response shift for my
research.
Data Analysis Plan
Using SEM techniques and LISREL 9.1 modeling software, I investigated
response shift in QoL data reported in the ISISS study to address the following research
questions:
1. Do treated back pain patients experience a difference in response shift
between baseline and 3 months and between baseline and 12 months
postintervention?
2. Does response shift phenomenon influence the clinical comparison of patientreported outcomes between baseline and 12 months in a randomized clinical
trial for a spine intervention?
This analysis plan contains an overview of the SEM methodology, study hypotheses with
acceptance criteria, an explanation of the initial model, and model respecification
alternatives.
SEM Process
To investigate response shift, I implemented the three-step SEM process
described by King-Kallimanis et al. (2010):
1. Establish a measurement model.
2. Test invariance across measurement occasions.
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3. Add exogenous variables and test direct effects.
Step 1: Measurement model. In the first step I developed a confirmatory factor
analysis (CFA) model that was an appropriate measurement model with good fit and
clear interpretation of the data. As recommended by Kline (2011), goodness of fit was
evaluated using two indicators—chi-square and root mean square error of approximation
(RMSEA). The chi-square value represents the equivalence of the model predicted
means, variances, and covariances compared to the observed means, variances, and
covariances and supports the assessment of a model’s overall goodness-of-fit. In general,
a good fit is indicated if the chi-square value is not significant. However since chi-square
values are a measure of exact fit, the results can exhibit significant sample size sensitivity
where in large samples even very small differences may be identified as significant.
Adding RMSEA, an index of approximate fit, to the evaluation overcomes this limitation.
RMSEA of < 0.08 was interpreted as a reasonable fit and < 0.05 as a close fit (BarclayGoddard et al., 2009; King-Kallimanis et al., 2011).
When initial fit was not acceptable, the model was respecified according to
theoretical associations outlined later in this chapter (Respecification Alternatives). I
repeated the respecification process until I obtained a model with reasonable fit values.
Step 2: Invariance across measurement occasions. Next, I used the SEM model
and a two-stage process to evaluate response shift. In the first stage, I assessed overall
response shift. Then I evaluated the model to detect the specific response shift
components of reconceptualization, reprioritization, and recalibration.
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Step 2, Stage 1: Overall response shift assessment. In the first stage, I assessed
invariance of the model across the study follow-up timepoints by constraining all factor
loadings and intercepts to be equal across baseline, 3-months, and 12-months. Using a
chi-square difference test, the new model was compared with the model from Step 1. The
chi-square difference statistic tests the hypothesis that two nested or hierarchical models
are equal (Kline, 2011). A significant result indicates the models are not equal and the
model with more free parameters fits the data better. Hierarchical models are those where
one model is related to the second model only by the addition or elimination of free
parameters. A significant chi-square difference result between the unconstrained (step 1)
and constrained (step 2) models indicates response shift (King-Kallimanis et al., 2010;
King-Kallimanis et al., 2011; King-Kallimanis et al., 2012).
To expand on this conclusion, recall that latent variables represent the true value
of the unmeasured attributes (i.e., wellbeing associated with physical aspects of life,
PQoL). Based on data covariance and means matrices, the unconstrained model (final
model from Step 1) provides a valid representation of the importance and contribution of
the observed variables (pain, function) on the latent variable. Oort’s (2005b) response
shift methodology focuses on these relationships. When multiple occasions are included
in the model, the use of validated instruments supports the assumption that the
relationship between the observed variables and the latent variables remains the same
across all occasions. For example, if pain explains 60% of PQoL at 3 months, pain should
also explain 60% of PQoL at 12 months even if the actual observed values of pain are
different at these two occasions. So when the variable relationships are the same at every
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occasion, changes in latent variable means will be fully explained by changes in the
observed variable means. Therefore, mathematically adding this assumption to the model
by including across occasion equality constraints should not significantly decrease the fit
of the model. When assessing the invariance of SEM models, Oort (2005b) identified
response shift when models were not equivalent and no response shift when the models
were equivalent. Therefore, a chi-square difference test that supports that the
unconstrained and constrained models are not equivalent also supports the finding of
response shift in the observed data.
Step 2, Stage 2: Evaluation of response shift components. The second stage of
invariance testing requires the sequential removal of constraints on individual variables to
assess the response shift components and detect their location (King-Kallimanis et al.,
2011; King-Kallimanis et al., 2012; Oort, 2005b). Working in iterative series addressing
each observed variable separately, I removed the equality constraints on factor loadings
and intercepts at all measurement occasions and assessed the fit using the chi-square
difference test. A significant chi-square difference was interpreted as response shift in the
associated parameter (Barclay & Tate, 2014; Oort, 2005b). To guard against family-wise
errors, I based significance of the chi-square difference test on Bonferroni adjusted levels
of significance (King-Kallimanis et al., 2011; King-Kallimanis et al., 2012). For each
series, the freed variable that was both significant and produced the largest chi-square
difference was retained to create an improved model. The process was repeated until the
model’s goodness of fit could not be further optimized.
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Oort (2005b) described and supported relationships between the three components
of response shift and changes in structural equation models. These relationships are
outlined in Table 4 and were used to guide the response shift component evaluation.
Table 4
Oort SEM Correlation to Response Shift Components
SEM findings over intervals
Factor-loading patterns

Response shift component
• Reconceptualization

Factor-loading magnitude

•

Reprioritization

Residual factor variances
Intercept changes

•
•

Recalibration - nonuniform
Recalibration - uniform

In Step 2, Stage 2, I evaluated the model components based on the Stage 1
optimized model and assessed response shift in the following order (a)
reconceptualization, (b) reprioritization, and (c) recalibration. In accordance with Oort
(2005b), reconceptualization analysis was based on the evaluation of the pattern of factor
loadings. Changes from zero to non-zero or positive to negative between measurement
occasions identified reconceptualization response shift. Reprioritization was based on a
comparison of the magnitude of factor loadings across occasions. Using standardized
factor loadings, I calculated the difference between each set of measurement occasions by
subtracting one from the other. Standardized factor loadings are correlation estimates
between the observed and latent variables and when squared (R2) are proportions of
explained variance. Consistent with King-Kallimanis et al. (2011) and SEM standard
practice (Kline, 2011), I interpreted a difference in factor loadings of 0.10 as significant.
Similarly, to identify recalibration, changes in residual factor variances (nonuniform
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recalibration) and intercepts (uniform recalibration) across measurement occasions were
assessed.
The requirement to characterize response shift components was guided by the
specific hypotheses tested in this research. Since the identification of at least one
component of response shift resolved the hypothesis, I ended the identification of
components after this occurred.
Step 3: Add exogenous variables. In the final step, I tested exogenous variable
invariance and investigated direct effects on the observed indicator variables. First, I
added the exogenous variable of interest, treatment group, to the model and assessed the
model for goodness of fit. Treatment group was free to correlate with PQoL and MQoL
while all direct effects were fixed to zero. To test observed variable invariance, I created
a series of models where the relationship between treatment group and the observed
variables were individually freed. A significant chi-square difference test and a parameter
change of at least 0.10 suggested a lack of invariance and a potential direct effect of the
exogenous variable on the observed variable (King-Kallimanis et al., 2010; KingKallimanis et al., 2011; King-Kallimanis et al., 2012). In each series, the parameter
associated with the largest significant improvement denoted a direct effect and was left
free to be estimated. I repeated the process until no further significant direct effects were
identified.
To identify potential chance findings and remain consistent with the methods of
other response shift researchers, I repeated the assessment for direct effects on a model
that included all available exogenous variables that could induce bias in QoL scores. The
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exogenous variables added were treatment group, age, gender, number of vertebral levels
treated, and BMI. I repeated the evaluation for direct effects using the new model. As the
purpose of this testing was to gain additional insights, I used this information to further
explain the results of the first Step 3 modeling assessment and not for hypothesis testing.
Hypotheses
H01: Response shift at 12 months is not different from response shift at 3 months.
RS12 = RS3
Ha1: Response shift at 12 months is different from response shift at 3 months.
RS12 ≠ RS3
where
RS12 is response shift of study population between baseline and 12 months, and
RS3 is response shift of study population between baseline and 3 months.
I evaluated the difference between response shift at 3 months and 12 months
based on the methodology outlined in SEM process, Step 2. After a SEM model with
good fit was determined from the research data (Step 1), the invariance of the model with
respect to measurement occasions was tested (Step 2, Stage 1) and response shift
components evaluated (Step 2, Stage 2).
For Stage 1, I added equality constraints and reassessed the model for goodness of
fit using LISREL software. I evaluated the results based on the following criteria
•

If the chi-square difference test between the constrained and unconstrained
models was not significant, the two models were interpreted as equivalent. If

83
the models were equivalent then no response shift across any timepoints was
identified and the null hypothesis was retained.
•

If the chi-square difference test between the constrained and unconstrained
models was significant, the models were not equivalent and response shift was
identified. However, since this test detects response shift over the entire model
(all three measurement occasions), additional analysis was required to assess
if there was a difference between the two timepoints of interest (the 3-month
and 12-month occasions). If required, I performed this Stage 2 analysis.

For Stage 2, I tested the model as described in SEM process, Step 2 and assessed
the components of response shift based on Oort’s (2005b) SEM correlation to response
shift components (Table 4). The null hypothesis was rejected if I identified any
component of response shift between the 3- and 12-month occasions. The null hypothesis
was retained if I identified no response shift between the 3- and 12-month occasions.
Response shift identified between other occasions was not used to address the hypothesis.
I discontinued evaluation of response shift once the hypothesis was addressed.
The three components of response shift (reconceptualization, reprioritization, and
recalibration) were assessed as follows. To determine reconceptualization, I reviewed the
factor loading patterns across occasions in the final model and evaluated the results based
on the following criteria.
•

If the pattern of factor loadings between 3 months and 12 months changed
(i.e. from non-zero to zero), reconceptualization was identified.
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•

If the pattern of factor loadings did not change, reconceptualization was not
identified.

For reprioritization, I calculated the difference in factor loadings across occasions
in the final model and evaluated the results based on the following criteria.
•

If the factor loading difference between occasions was at least 0.10,
reprioritization was identified in that parameter.

•

If the factor loading difference was less than 0.10, reprioritization was not
identified.

For recalibration, I calculated the difference in residual factor variances across
occasions in the final model and evaluated the results based on the following criteria.
•

If the residual factor variance difference between occasions was at least 0.10,
nonuniform recalibration was identified in that parameter.

•

If the residual factor variance difference was less than 0.10, nonuniform
recalibration was not identified.

H02: Response shift found in the patient-reported outcome results for treatment
group A at 12 months is not different from the response shift in treatment group B at 12
months.
RSA = RSB
Ha2: Response shift found in the patient-reported outcome results for treatment
group A at 12 months is different from the response shift in treatment group B at 12
months.
RSA ≠ RSB
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where
RSA is response shift of treatment group A at 12 months, and
RSB is response shift of treatment group B at 12 months.
I evaluated the impact of response shift between Treatment A and Treatment B
subgroups at 12 months based on the methodology outlined in SEM process, Step 3. With
treatment group added as an exogenous variable, the model was assessed for goodness of
fit and evaluated for direct effects. I used the following criteria to assess Hypothesis 2.
•

If the optimized model included a direct effect for the exogenous variable
treatment group that varied between measurement occasions, the null
hypothesis was rejected.

•

If no direct effect was demonstrated or the direct effect was equivalent
between measurement occasions, the null hypothesis was retained.

Model Parameters
The first step of the SEM was creating a confirmatory factor analysis model that
associated latent and observed variables. For this research, I identified the latent,
observed, and exogenous variables as follows:
Latent variables. Two latent variables were used in the SEM model, PQoL and
MQoL. These variables are consistent with general QoL research and the design of the
SF-12 (Oort et al., 2005).
Observed variables. Observed variables were provided by the QoL and function
instruments collected in the ISISS study—the ZCQ, ODI, SF-12, and VAS for back and
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legs. Continuous variables such as scales and domains were preferred over item
responses in accordance with SEM best practices (Kline, 2011).
Exogenous variables. The primary exogenous variable was treatment group to
support the testing of hypothesis 2. Additional exogenous variables (age, gender, number
of vertebral levels treated, and BMI) were also evaluated to better understand potential
demographic and surgical confounding factors.
Initial Model
Based on instrument design, literature sources (King-Kallimanis et al., 2011), and
theory, I created an initial model that contained six observed variables for PQoL (ZCQ
Parts 1 and 2, ODI, PCS of the SF-12, back VAS and leg VAS) and three observed
variables for MQoL (ZCQ Part 3 for 3-month and 12-month follow-ups, Mental Health
and Role Emotional domains of the SF-12) included. The measures and their scales are
summarized in Table 5.
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Table 5
QoL Indices Used in Initial SEM Model
Instrument

Item

ZCQ - Lumbar spinal
stenosis specific

•
•
•

Part 1: Symptom severity
Part 2: Physical function
Part 3: Satisfaction

0 – 100; % of maximum, higher
scores indicate increased
symptoms, decreased function,
decreased satisfaction

ODI - Spine disorders
specific

•

Disability composite

0 – 100; % of maximum, higher
scores indicate increased
disability

SF-12 -Generic health
profile

•

PCS: Physical composite subscore

0 – 100; higher scores indicate
better physical health

•
•

MH: Mental health domain
RE: Role emotional domain

0 – 100; higher scores indicate
better mental status

•

Back pain severity

0 – 100; higher scores indicate
increased pain

•

Leg pain severity – addition of
right and left leg VAS scores to
create one variable

Pain VAS - Pain
severity measure

Scale

0 – 200; higher scores indicate
increased pain

The relationships between the latent variables and observed variables were based
on the instrument design with physical and pain measures associated with PQoL and
mental components associated with MQoL. The resulting path diagram is presented in
Figure 2.
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Figure 2. Path diagram of 12-month follow-up. ZCQ1 = Zurich claudication
questionnaire-symptom severity, ZCQ2 = Zurich claudication questionnaire-physical
function, ODI = Oswestry disability index, PCS = physical component of SF-12, BVAS
= back visual analog scale, LVAS = leg visual analog scale, ZCQ3 = Zurich claudication
questionnaire-satisfaction, MH = mental health domain of SF-12, and RE = role
emotional domain of SF-12.
Since multiple intervals were included in the model, the final path model included
three timepoints. The resulting initial model is represented by Figure 3.

Figure 3. Path diagram for initial model. Note: Baseline timepoint has one less observed
variable for Mental QoL as ZCQ3, Satisfaction with treatment, is not completed at
baseline.
Respecification Alternatives
Model building was guided by theory and empirical results from previous
research. In accordance with best practices for SEM, the following respecification
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alternatives were documented prior to estimating the initial structural equation model.
First, due to the potential for overlap in variables that measure either pain or physical
function parameters, theory supports correlation between variables that would make the
inclusion of multiple variables redundant. Kline (2011) recommended that redundant
variables be removed from the model to support parsimony. If modification indices and
standardized residuals support fewer indicators, the removal or substitution of indicators
within the attribute groups in Table 6 would be supported by theory.
Incidental correlations when two indicators have more in common than the
common factors are also theoretically justified (Oort, 2005c). Additionally, relationships
may exist between theoretically related factors. King-Kallimanis et al. (2011) identified
covariance in an SF-12 SEM model between mental health (MH) and role emotional
(RE).
Table 6
Model Indicators Grouped by Attribute
Attribute
Pain

Indicators
ZCQ1 (symptom severity scored by ZCQ)
BVAS (back pain scored by VAS)
LVAS (leg pain scored by VAS)
BP (bodily pain scored by SF-12)

Physical Function

ZCQ2 (physical function scored by ZCQ)
ODI (disability scored by ODI)
PCS (physical component score of SF-12)
PF (physical function scored by SF-12)
RP (role physical scored by SF-12)
GH (general health scored by SF-12)
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Another alternative to simplify the model would be to remove the indicators
associated with pain. Symptom severity and pain scores, especially 12 months after an
intervention and in an older population, may be attributed to factors other than spine
issues. Some may be chronic while others transient, e.g. subjects overexerted by playing
36 holes of golf in the days prior to the follow-up visit. Therefore, pain may not be as
relevant as physical function when evaluating back issues. Removal of the pain indicators
would be theoretically justified if a simpler model was required.
Human Subject Protection and Research Validity
Walden University Institutional Review Board approved this research under IRB
approval #05-08-14-0201068. As secondary analysis of data collected in a separate
clinical trial, this research included no direct access to the human subjects. The original
data continues to be maintained by VertiFlex and does not contain names or other subject
unique identifiers, instead using unique subject screening numbers. For this research, the
original screening number was replaced with a new identification number known only to
VertiFlex to further enhance privacy protection. Human protection of subjects enrolled in
the primary ISISS study was conducted in compliance with 21 CFR 56 where clinical
investigators and the study sponsor, VertiFlex, verified that prior to study enrollment IRB
approval was granted and all subjects signed informed consents. For this secondary
analysis, I used the limited dataset only as permitted by this plan and as required by law
and implemented safeguards to prevent inappropriate use or disclosure of the dataset.
When the dataset is no longer required, I will destroy it in compliance with the Walden
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University dissertation support requirements. I will also ensure that all Walden IRB
requirements and conditions are met.
Threats to external validity, inappropriate generalization to populations not
included in the research, have been mitigated by highlighting the research patient
population as subjects in the United States who suffered from moderate lumbar spinal
stenosis, who agreed to implantation of a minimally invasive medical device and were
followed for 12 months. As health care literature has identified divergent response shift
based on patient condition, outcomes, and follow-up interval, the results of this research
may not be generalizable to other patient populations or other intervals. As secondary
research based on experimental data from a randomized clinical trial, the design of the
primary ISISS study addressed internal validity threats. Selection bias, differences in the
study population, and experimenter bias have been mitigated by the use of required
inclusion criteria and randomization. Additionally, instrument and study procedures were
prescribed in detail and maintained throughout the study. Finally, the inability of the
measurement instrument to measure the variables of interest, construct validity, has been
mitigated by the use of advanced modeling techniques. SEM integrates multiple variables
into the same model. Comparing changes in response shift and not characterizing the
specific response shift, enabled any construct issues to be excluded from the analysis.
Overall, while internal and external validity are always important, the design of this
research has mitigated the potential impact of these research issues.
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Summary
Changes in the internal standards, values, and priorities that patients use to assess
health related QoL over time, response shift, could impact the results and conclusions of
medical device clinical trials that use patient-reported outcome measures as primary
endpoints. I used SEM to evaluate response shift using data from a randomized clinical
trial of a spine intervention comparative study. The three-step SEM framework presented
by King-Kallimanis et al. (2010) was used to evaluate response shift in the data. Overall,
this chapter contained the research study design, study population, instrumentation, and a
practical and effective SEM methodology to evaluate response shift in longitudinal
comparative clinical trial data.
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Chapter 4: Results
The purpose of this research was to explore the impact of response shift on
clinical trial data interpretation at 1 year in an interventional spine clinical trial.
Specifically, I investigated the difference in response shift experienced by patients
between two measurement occasions. I also researched if the intervention the subject was
randomly assigned impacted response shift in a way that could influence clinical
interpretation. To investigate response shift, I developed a confirmatory path model and
used it to test invariance over measurement occasions and the direct effect of patient
characteristics. This chapter contains the results of the research including a data
summary, the measurement model with goodness of fit results, and hypothesis testing.
Results
Population
From the ISISS study data collected between June 2008 and May 2012, I
identified 288 subjects who had received a study interspinous medical device and had
reached 12-month enrollment. Of these, 263 subjects reported 12-month QoL results. As
the ISSIS study was designed to collect a representative sample of lumbar spinal stenosis
subjects, this research subset should also be representative of this spine population. Data
were limited only by 12-month follow-up data availability as I performed no sampling.
The number of subjects unavailable (8.6%) was also consistent with the study expected
loss to follow-up rate of 10%. The research population had an average age of 67.1 years,
was 63% male, and 54% had two vertebral levels treated (Table 7). Ninety-seven percent
of the subjects had data for all three timepoints (baseline, 3 months, and 12 months).

94
Table 7
Demographics
Variable
Subjects (n =)

263

Age: Mean (SD)

67.1 (9.6) years

Race:

95% White
2% African American
2% Other

Gender

63% Male
37% Female

Vertebral levels treated

46% 1 Level
54% 2 Levels

BMI: Mean (SD)

29.7 (4.7)

Treatment Group

45% Group A
55% Group B

Intervals

97% Baseline, 3- & 12-month
3% Baseline & 12-month

Baseline ZCQ: Mean (SD)

3.28 (0.61) – ZCQ1
2.67 (0.43) – ZCQ2

Baseline ODI: Mean (SD)

39.51 (12.82)

Baseline VAS: Mean (SD)

56.75 (25.84) – Back (max = 100)
99.50 (48.39) – Legs (max = 200)

Baseline SF-12: Mean (SD)

28.53 (8.24) – PCS
49.86 (13.05)– MCS

Note. ZCQ = Zurich Claudication Questionnaire; VAS = Visual Analog Scale for pain;
ODI = Oswestry Disability Index; SF-12 = Short form general health survey; PCS =
Physical Composite Subscale; MCS = Mental Composite Subscale.
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I prepared the data using LISREL 9.1 software (Scientific Software International,
2013). To consolidate the Excel datasets into a single dataset, I separated the variables
based on follow-up interval, converted ordinal and alpha data into numbers, and renamed
labels to comply with LISREL software requirements. I imported the raw data into
LISREL and ran the LISREL Statistics Data screening function to summarize the data.
The LISREL standard full information maximum likelihood (FIML) estimation method
was used to address missing data.
Across Occasion Response Shift
Hypothesis 1 testing required two steps—identifying an appropriate measurement
model and testing for across occasion invariance as outlined in Chapter 3, SEM Process,
Steps 1 and 2. To perform this analysis, I created and evaluated a series of models. Table
8 contains the association of observed variables with latent variables for these models and
Table 9 presents the results of goodness of fit assessments.

96
Table 8
Observed and Latent Variables for Each Research Model
Exogenous
Variables
none

Figure 3

MH, RE

none

-

ZCQ2, BVAS,
PF, BP, RE

MH, RE

none

-

Across occasion
factor loadings constrained equal

ZCQ2, BVAS,
PF, BP, RE

MH, RE

none

-

2.2F

Factor loadings
freed

ZCQ2, BVAS,
PF, BP, RE

MH, RE

none

-

3.0

Model 2.2F plus
Treatment group

ZCQ2, BVAS,
PF, BP, RE

MH, RE

Treatment Group

-

3.1

Model 2.2F plus
all exogenous
variables

ZCQ2, BVAS,
PF, BP, RE

MH, RE

Treatment
Group, Age,
Gender, Levels
Treated, BMI

Figure 4

Model
Initial Model
1.0

PQoL
ZCQ1, ZCQ2,
ODI, PCS,
BVAS, LVAS

MQoL
ZCQ3,
MH, RE

1.1

Initial Model
with ZCQ3
removed

ZCQ1, ZCQ2,
ODI, PCS,
BVAS, LVAS

1.2F

Modified Model
- Final

2.1

Note. F denotes final model for steps 1 and 2. PQoL = Physical Quality of Life; MQoL =
Mental Quality of Life; ZCQ1 = Zurich Claudication Questionnaire Part 1; ZCQ2 =
Zurich Claudication Questionnaire Part 2; ZCQ3 = Zurich Claudication Questionnaire
Part 3; ODI = Oswestry Disability Index; PCS = Physical Composite Subscale; BVAS =
Back Visual Analog Scale; LVAS = Leg Visual Analog Scale; PF = Physical Function;
BP = Bodily Pain; RE = Role Emotional; MH = Mental Health; BMI = Body Mass Index.
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Table 9
Overall Goodness of Fit and Chi-square Difference Test Results

Model
1.0

Initial Model

Goodness of fit parameters
RMSEA
χ2
2
χ
(90% conf
DIFF
(df)
int)
(df)
p
1104.5
0.105
(284) (0.098; 0.111)

Models
Compared
None

1.1

Initial Model with
ZCQ3 removed

931.1
(237)

0.106
(0.098; 0.113)

173.4
(47)

<0.0001

1.1 vs. 1.0

1.2F

Modified Model Final

282.3
(114)

0.075
(0.068; 0.089)

648.8
(123)

<0.0001

1.2 vs. 1.1

2.1

Across occasion
factor loadings constrained equal

426.7
(128)

0.096
(0.087; 0.107)

144.4
(14)

<0.0001

2.1 vs. 1.2

2.2F

Factor loadings
freed - ZCQ2, PF,
BVAS, BP, & RE

302.5
(116)

0.078
(0.068; 0.089)

124.2
(12)

<0.0001

2.2 vs. 2.1

3.0

Model 2.2F plus
Treatment group

297.5
(128)

0.071
(0.060; 0.081)

Not
applicable

3.1

Model 2.2F plus
all exogenous
variables

370.3
(176)

0.065
(0.056; 0.074)

Not
applicable

Note. F denotes final model for steps 1 and 2. RMSEA = root mean square error of
approximation; χ2DIFF = chi-square difference.
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Model 1.0. First, I reviewed the theoretically justified structural equation model
outlined in Chapter 3 (Figure 3). In this model, the observed variables ZCQ1, ZCQ2,
ODI, PCS, BVAS, and LVAS were associated with PQoL. Variables ZCQ3, MH, and RE
were associated with MQoL (Table 8, Model 1.0). Based on chi-square and RMSEA
statistics, this model was not a good fit to the data (Table 9, Model 1.0). King-Kallimanis
et al. (2011) highlighted that in longitudinal models the pattern of factor loadings must be
consistent across all occasions. As Model 1.0 did not meet this criterion, I removed
ZCQ3 from loading on MQoL at the 3- and 12-month occasions. ZCQ3 could not be
added to the baseline timepoint as the instrument did not include ZCQ3 prior to an
intervention.
Model 1.1. By testing the adjusted Model 1.1 using LISREL 9.1 software, I found
the model did not fit the data (Table 9, Model 1.1) as the chi-square test was significant
and RMSEA was greater than 0.08 (RMSEA = 0.108).
Model 1.2F. Using the pre-specified adjustments outlined in Chapter 3
Respecification Alternatives, I investigated a number of alternative models by
substituting, replacing, and removing observed variables. Through this process, I tested
an updated model that associated the observed variables of ZCQ2, BVAS, PF, and BP
with PQoL; and RE and MH with MQoL (Table 9, Model 1.1). The fit was unsatisfactory
(RMSEA = 0.106). Inspection of the modification indices suggested cross-loading of RE
onto PQoL (including role emotional in both PQoL and MQoL assessments) and the
addition of an error covariance between BVAS and PF (back pain and general physical
function). I determined these associations to be theoretically sound. No other suggested
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modifications could be supported by theory and so I did not include them. The changes
produced a model with satisfactory fit (Table 9, Model 1.2F) where even though the chisquare test was significant, the RMSEA was less than 0.08 indicating the model had
reasonable fit. The path diagram and output files are found in Appendix B. The final
model was theoretically justified as condition-specific and general wellbeing QoL scores
documenting observed function, pain, and mental from several instruments were
combined. As the model fit was satisfactory and interpretation clear, I proceeded to the
next step.
Model 2.1. To evaluate across occasion response shift, I constrained all factor
loadings and intercepts to be equal across the three measurement occasions and created
Model 2.1. The fit of this model was significantly worse when compared to Model 1.2F
(χ2 DIFF = 144.4, df = 14, p = <0.0001, α = 0.05) indicating that response shift existed
between measurement occasions (Table 9, Model 1.2F). This analysis supported the first
stage of Hypothesis 1 testing. To comply with the hypothesis testing plan further
evaluation of individual response shift components was required so I conducted the next
stage of assessments.
Model 2.2F. To identify the magnitude and type of response shift at the 3- and
12-month occasions, I optimized the model by removing the equality constraints from
each variable independently and comparing the fit of the resulting model. In each series, I
freed the observed variable that was both significant and yielded the largest
improvement. This process was repeated until no models in the next series showed
significant improvement in the chi-square difference parameter. I created and assessed a
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total of 30 models (Appendix C). To minimize family-wise error and reduce chance
findings in this iterative testing, I determined significance using the Bonferroni adjusted
level of significance α* = αf/(nznt) where αf was the family-wise level of significance, nz,
was the number of factor loadings fixed at zero for a single measurement occasion, and nt
was the number of measurement occasions (King-Kallimanis, 2010).
Based on this iterative assessment, I identified that freeing RE, BP, ZCQ2,
BVAS, and PF would improve model fit and confirmed that response shift existed in
these variables across measurement occasions. Comparison of the final Model 2.2F to
Model 2.1 indicated that Model 2.2F was improved (χ2 DIFF = 124.2, df = 12, p =
<0.0001, α = 0.05). I performed this analysis to develop the model rather than to conduct
hypothesis tests. I then continued my evaluation by assessing individual response shift
components.
For detection of reconceptualization and using Model 2.2F, I assessed the factorloading patterns between 3 and 12 months and identified no change (Table 10).
Therefore, no reconceptualization between 3 months and 12 months was demonstrated.
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Table 10
Standardized Factor Loadings for Model 2.2F

Baseline Factor Loadings

ZCQ2
0.66

BVAS
0.36

PQoL
PF
-0.64

BP
-0.60

RE
-0.19

MQoL
MH
RE
0.61
0.93

3-month Factor Loadings

0.81

0.66

-0.77

-0.85

-0.19

0.43

0.97

12-month Factor Loadings

0.87

0.83

-0.83

-0.87

-0.42

0.36

1.03

Baseline and 3-month
Factor Loadings Difference
Baseline and 12-months
Factor Loadings Difference

0.15

0.30

0.13

0.25

0

0.18

0.04

0.21

0.47

0.19

0.27

0.23

0.25

0.10

3-month and 12-month
Factor Loadings Difference

0.06

0.17

0.06

0.02

0.23

0.07

0.06

Note. Differences in factor loadings > .10 are in boldface. PQoL = Physical Quality of
Life; MQoL = Mental Quality of Life; ZCQ2 = Zurich Claudication Questionnaire Part 2;
BVAS = Back Visual Analog Scale; PF = Physical Function; BP = Bodily Pain; RE =
Role Emotional; MH = Mental Health.
Testing for reprioritization, I compared the magnitude of factor loadings between
measurement occasions (Table 10). Reprioritization response shift was identified between
baseline and both follow-up timepoints as multiple loadings differed by at least 0.10. All
observed variables were impacted between baseline and 12 months and a majority of
variables (71%) were impacted between baseline and 3 months. Since I did not identify
significant response shift in MH in Stage 1, the borderline factor-loading difference in
this variable at 12 months could be a chance finding.
For assessment of Hypothesis 1, I focused on the differences between the 3month and 12-month timepoints and identified a change in factor-loading magnitude of at
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least 0.10 for two variables—the BVAS standardized factor loadings differed by 0.17 and
RE loadings on PQoL differed by 0.23 (Table 10). Therefore, the change in factorloading magnitude was significant and indicated reprioritization response shift between 3
month and 12 months.
Based on the two-stage Hypothesis 1 analysis, I rejected the null hypothesis. In
Stage 1, response shift was identified based on the comparison of Model 1.2F and Model
2.1. Specifically, the chi-square difference test was significant (p = <0.0001, α = 0.05)
denoting the models were not equivalent. In Stage 2, I identified reprioritization response
shift between 3 months and 12 months based on a difference of at least 0.10 in the factor
loading magnitude of two observed variables, BVAS and RE. Based on the rejection of
the null hypothesis, I concluded that response shift at 12 months was different than
response shift at 3 months. As no further testing of hypothesis 1 was required, I moved on
to the analysis of hypothesis 2 and did not evaluate the model for recalibration response
shift components.
Influence of Treatment Group on Response Shift
Hypothesis 2 testing required the addition of exogenous variables, specifically
treatment group, to the final Step 2 model to assess the direct effects of patient and
surgical characteristics. To support this analysis, I created and assessed two additional
models, Model 3.0 and 3.1 (Table 8). Consistent with earlier analysis, model goodness of
fit was assessed based on chi-square and RMSEA. Direct effects were assessed based on
chi-square difference statistics using Bonferroni adjusted levels of significance.
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Model 3.0. To create Model 3.0, I added the treatment group variable to Model
2.2F and allowed it to correlate with PQoL and MQoL. I fixed all direct effects on the
observed variables to zero. The fit of Model 3.0 was satisfactory (χ2 = 297.5, df = 128,
RMSEA = 0.071). Since the relationship between Model 3.0 and Model 2.2F was not
hierarchical, the chi-square difference test was not a valid test statistic and was not
assessed (Kline, 2011).
To test for direct effects, I created a series of models associating treatment group
with each observed variable separately. The series contained six models and I assessed
significance based on α* = 0.0083. In this series when I associated treatment group and
MH, the LISREL software produced illogical results and the warning that the covariance
matrix was not positively definitive. As the estimation methods employed by the LISREL
software require a positive definite matrix, I determined that this result was
uninterpretable and could not support the finding of a direct effect. The variable MH was
removed from the analysis procedure.
I did not identify any direct effects based on treatment group as no unconstrained
models met the criteria of a significant chi-square difference test (at adjusted significance
levels) and parameter changes greater than 0.10. Based on these data, I did not reject the
null hypothesis that subjects who received treatment A did not experience a difference in
response shift from subjects who received treatment B between any measurement
occasions. Since I detected no response shift bias based on treatment group, I further
determined that there was no evidence to support that response shift influenced the direct
comparison of QoL data between baseline and 12 months in the ISISS study.
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Model 3.1. To provide additional information concerning the impact of
exogenous variables on the study results, I added age, gender, levels treated, and BMI to
Model 3.0 to create Model 3.1 (Table 8). Exogenous variables were allowed to correlate
with latent variables while all direct effects on the observed variables were fixed to zero
(Figure 4). While available, I did not include race as an exogenous variable as my review
of the demographic data found the population to be almost homogenous at 95% white
(Table 7).

Figure 4. Graphical display of Model 3.1 showing first occasion variables only. QoL =
quality of life; BMI = body mass index; ZCQ2 = Zurich claudication questionnaire part
2; BVAS = back visual analog scale; PF = physical function; BP = bodily pain; RE = role
emotional; MH = mental health.
The fit of Model 3.1 was satisfactory (χ2 = 370.3, df = 176, RMSEA = 0.065).
The path diagram and output files are found in Appendix D. In my review of the resulting
covariance matrix (Table 11), I confirmed that treatment group had an extremely small
covariance with PQoL and MQoL across all occasions. I interpreted this as not
contradicting the previous finding that treatment group had no direct effect even when
multiple exogenous factors were included in the model.
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Table 11
Model 3.1 Covariances
MQoL
T1

PQoL -T1

PQoL
T1
1

PQoL
T2

MQoL
T2

PQoL
T3

MQoL
T3

MQoL -T1

-0.37

1

PQoL –T2

0.46

-0.18

1

MQoL –T2

-0.22

0.47

-.050

1

PQoL –T3

0.47

-0.18

0.73

-0.43

1

MQoL –T3

-0.18

0.42

-0.30

0.49

-0.47

1

Treatment group

-0.04

0.03

0.03

-0.02

-0.01

-0.01

Age

-0.03

1.72

1.71

0.73

1.80

0.10

Gender

0.13

-0.07

0.06

-0.04

0.04

-0.03

Levels treated

0.06

0.01

0.03

0.002

0.03

-0.01

BMI

1.10

-0.46

0.33

-0.53

-0.07

-0.09

Note. PQoL = Physical Quality of Life; MQoL = Mental Quality of Life; BMI = Body
Mass Index.
To detect significant direct effects in this updated model, I repeated the analysis
process outlined for Model 3.0 by created a series of iterative models. The series
contained 30 models and significance was assessed based on α* = 0.016. As in the earlier
Step 3 analysis, models created to assess MH for all exogenous variables were
uninterpretable and removed from consideration for being freed. In the first series, no
significant direct effects were associated with treatment group at any occasion.
Significant direct effects of age and gender on RE were suggested but as the results from
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this series supported no direct effect of treatment group, I did not follow-up with the
additional testing to fully characterize the model’s direct effects. I concluded that the
analysis of adding additional exogenous factors to the model did not raise any questions
concerning the retention of the null hypothesis for Hypothesis 2 and provided additional
support for the previous findings.
Summary
I concluded that the answer to research question 1 was that back pain patients in
the ISISS study did experience a difference in response shift between baseline and 3
months and between baseline and 12 months postintervention based on the rejection of
the null hypothesis. I rejected the null hypothesis as a result of my detection of response
shift in the overall model (Stage 1 test) in addition to the identification of reprioritization
response shift between 3 months and 12 months (Stage 2 test). Specifically in Stage 1, the
chi-square difference test between models 1.2F and 2.1 was significant (p = <0.0001, α =
0.05) indicating that the models were not equivalent and overall response shift was
detected. In Stage 2, my comparison of the magnitude of factor-loading values between
occasions identified a difference greater than 0.10 between the 3 month and 12 month
measurement occasions that I interpreted as reprioritization response shift between these
two follow-ups.
For research question 2, I found there was insufficient evidence to conclude that
response shift phenomenon impacted the clinical comparison of patient-reported
outcomes between baseline and 12 months in the ISISS study based on the failure to
reject the null hypothesis. I did not reject the null hypothesis that subjects who received

107
treatment A did not experience a difference in response shift from subjects who received
treatment B between any measurement occasions as a result of my SEM analysis into
direct effects using Model 3.1. Specifically, I identified no unconstrained models in my
iterative analysis of treatment group that met the criteria of a significant chi-square
difference test (α = 0.0083) and parameter changes greater than 0.10. Therefore since a
difference in response shift between the two treatment groups was not detected, I
determined ISISS investigators could conduct direct clinical comparison of the treatment
group results without accounting for differing response shift influences. In Chapter 5, I
present further discussion of the results of this modeling study and implications for the
integration of response shift analysis in the clinical interpretation of clinical data. I also
explore how this research can result in positive social change and make recommendations
for practice and future research.
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Chapter 5: Discussion, Conclusions, and Recommendations
In this research, I investigated the impact of response shift phenomenon in a
lumbar spinal stenosis population after receiving a surgical intervention. Using SEM
techniques, I identified reprioritization at both 3 and 12 months with this response shift
changing between the two follow-up timepoints. In my analysis of exogenous factor
influence on response shift, I found that treatment group did not significantly impact the
QoL reporting at 12 months. These findings add to the response shift body of knowledge
by documenting that response shift was found in a spinal intervention population,
reprioritization was different at different timepoints, and that direct comparisons between
treatment groups can be made with no requirement to adjust for response shift. In this
chapter, I expand on the interpretation of the findings, discuss other aspects of the
research, and make recommendations for practice and future research.
Interpretation
In the evaluation of the clinical data, I identified response shift that differed
between the 3- and 12-month follow-ups. The change in factor loadings between
measurement occasions supported the finding that reprioritization response shift impacted
BVAS (back pain as measured by the VAS pain scale) and RE (role limitations based on
emotional issues). As reprioritization represents a change in the way a patient values
specific aspects of his or her health, this change indicated that the back pain the patients
experienced at 12 months had a greater influence on their perceived physical well-being
than it did at 3 months. Likewise, I found that the correlation between RE and the
patient’s PQoL scores increased between the 3- and 12-month follow-ups. The
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correlation was negative because, unlike the other scales that make up PQoL, increased
SF-12 measures indicated improved patient status. Reprioritization change in back pain
could indicate that patients at 3 months may not have considered themselves fully healed
from their surgery and so they associated less of their physical wellbeing to their back
pain. It is also possible that the general reduction in pain and the fact that some patients
may still have been medicated for surgical pain could also influence the relationship
between back pain and overall QoL. Conversely, most patients at 12 months had accepted
that the level of pain they were experiencing had stabilized. This realization could
influence them to assign more importance to the pain they were experiencing when
scoring their QoL.
In a similar way, physical limitations due to emotional conditions such as
depression and anxiety may be included in the patient’s general QoL scores differently at
3 and 12 months. Because patients were completing the instruments on a regular basis
and, in general, their physical status was improving, it is also possible that the
respondents were better able to differentiate between emotional and physical causes for
limitations in their day-to-day lives. These factors could also support reprioritization
response shift. It is interesting to note that RE retained similar importance, no
reprioritization, when predicting MQoL between these two follow-ups. These easily
understood explanations can be used to support the reasoning that the response shift
identified in the data was not a chance finding.
In the evaluation of patient and surgical characteristics on response shift, the
addition of exogenous variables in both Models 3.0 and 3.1 improved the model fit to the
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data (Table 9). However, unlike in drug trials where both patient and investigator can be
blinded to treatment arm, many device trials, especially those that involve surgical
implants, cannot keep this information from the subject. Receiving the experimental or
control treatment may influence a patient’s expectations for recovery and symptom
resolution, as the potential benefits of the new treatment are covered extensively in the
informed consent phase of a clinical trial. Disappointment in treatment assignment, an
expectation of faster or miraculous healing if the experimental treatment was received, or
other differences in expectations could influence QoL reporting and thereby bias a direct
comparison of the outcome measures. Finding no direct effects of treatment group on
response shift supported the direct comparison of the two study arms. While randomized
clinical trial designs implemented by experienced research staff should reduce treatment
group bias significantly, having an additional tool for confirmation could increase
confidence in the clinical conclusions made by investigators. In this research, the
identification of a potential direct effect associated with age and gender could be used to
better understand specific subpopulations, direct future research, and prevent inaccurate
ad hoc conclusions concerning the results.
Discussion
The response shift theoretical model includes the requirement for a catalyst,
defined as a change in an individual’s health state regardless of source or direction
(Sprangers & Schwartz, 1999). Therefore, the identification of a significant difference in
response shift between 3 and 12 months supported time, in addition to the intervention, as
a catalyst event in this spine intervention population. This finding was consistent with a
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previous orthopedic intervention study that identified response shift between 6 and 12
months after surgery and found response shift confounded the accurate measurement of
patient recovery (Razmjou et al., 2009). However, when evaluating response shift in
other medical conditions, researchers have documented varied results. In multiple
sclerosis patients followed for 18 months, King-Kallimanis et al. (2011) identified only a
small response shift. As the population was selected based on an expectation of large
response shift, this finding was unexpected and the researchers identified the lack of a
catalyst event as one of the reasons for the findings. In a study of an HIV/AIDS
population that covered 2 years, King-Kallimanis et al. (2010) found minimal response
shift. The researchers again highlighted the lack of a specific catalyst event such as a new
diagnosis or an intervention as a study limitation. Conversely, in a longitudinal study of
older men who both had strokes and were stroke free, reprioritization response shift was
identified in all groups (Barclay & Tate, 2014). Covering 4 years, these results could
indicate that time did serve as a sufficient catalyst event in the stroke-free older male
population. The limited body of knowledge related to response shift and catalyst events
does not provide any actionable results. However, whether time serves as a trigger for
response shift could have significant implications for medical research as, if confirmed,
this finding could invalidate accepted conclusions from previous longitudinal trials.
Increased understanding of the impact in different acute and chronic conditions could
also require significant changes in accepted clinical trial design and expectations.
While theoretically complex, I was able to assess response shift in patientreported outcome measurements effectively from a comparative clinical trial by applying
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SEM techniques. The process was fairly time consuming but the final results were
interpretable and credible. By tailoring the process to focus on aspects relevant to
comparative clinical trials, I was able to simplify the technique to a small degree. The
primary challenge I had implementing SEM was in identifying an adequate starting
measurement model because no other researchers had validated a SEM QoL model for a
lumbar spinal stenosis surgical population. One early decision I had to make was whether
to include only one or multiple instruments in the model. Literature did not provide any
recommendations as both single and multiple instrument models had been used
successfully (Ahmed et al., 2009; Barclay & Tate, 2014; Barclay-Goddard et al., 2009;
King-Kallimanis et al., 2010). I elected to incorporate multiple instruments because five
instruments were used in the ISISS study to support the analysis of primary and
secondary endpoints. In addition, it was not feasible to use only the primary assessment
instrument, the ZCQ, as the limited number of parameters violated model identification
requirements. I did try to include at least one ZCQ variable in the final model as this
instrument was critical to the primary treatment comparison and it was the only disease
specific measurement tool. Because researchers had identified that even in the same
studies, spine patients reported diverse and conflicting results when different instruments
were used (Copay et al., 2010; Schwartz & Finkelstein, 2009), the difficulty in
identifying a starting model was not unexpected. Another decision I made in the SEM
process was whether to require reasonable fit (RMSEA < 0.08) or close fit (RMSEA <
0.05) goodness of fit criteria. I selected reasonable fit as sufficient because the purpose of
my research was to assess response shift in the context of interpreting comparative
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clinical data and not to determine cause and effect relationships or to quantify true
change. Other researchers had made the same decision (Ahmed et al., 2009; Barclay &
Tate, 2014).
In the health care literature, I found a general consensus on the importance of
assessing response shift when QoL endpoints were used to support clinical efficacy
decisions (Ahmed et al., 2005; Barclay & Tate, 2014; Hamidou et al., 2011; KingKallimanis et al., 2012; Razmjou et al., 2009; Schwartz et al., 2006). However, there was
significant variability in the ability of different methods to identify the same response
shift. In direct comparisons, different methods yielded discrepant results in type of
response shift, effect size, clinical significance, or a combination of these (Ahmed et al.,
2005; Nagl & Farin, 2012; Visser et al., 2005). Therefore, with no validated or standard
methodology for determining true change, how should investigators address response
shift when it is identified? How can the potential for response shift bias be minimized as
part of the clinical study design? In some cases, an evaluation of response shift will
confirm that this phenomenon does not invalidate a direct comparison. In this research,
the finding that treatment group did not influence the data at 12 months provided an
example of this and the ISSIS investigator would be correct in implementing standard
comparative analysis. However, investigators cannot count on the absence of significant
response shift and therefore methods to address this phenomenon should be included in
the initial study design. Techniques used to address other potential biases could be
adapted such as including prespecified decision points and significance levels in study
procedures and analysis plans. To do this, investigators would need to consider and
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document the potential relationships between the types of response shift and research
questions, study design, data structure, and specific QoL instruments. This could be a
monumental task since relevant parameters increase exponentially when complex
relationships are modeled. An additional complication with this approach would be that
when response shift was identified, the investigator would need to report specifically how
the information was integrated into the clinical interpretation. At a minimum, this should
include the impact of recalibration, reprioritization, and reconceptualization.
Alternatively, given the lack of accepted response shift adjustment information,
investigators could select a clinical study design to minimize the potential impact of
response shift. Eliminating the requirement to adjust QoL measures for response shift
could be accomplished by using an equivalency or non-inferiority hypothesis in place of
a direct comparison or superiority analysis. However, these equivalency designs could
impose significant restrictions since a comparison treatment that was both equivalent and
ethically valid would be required. Additionally, treatments that were superior to existing
options, a typical goal of new interventions, often would not meet equivalency criteria.
Limitations of the study
During analysis, I did not identify any additional limitations to this research.
However, the previously identified limitations remained. First, the study design was
based on secondary analysis of previously collected experimental clinical trial data and as
such the design did not drive data collection. However, sufficient data to support the
SEM methodology was available so this restriction did not have a negative impact on the
study. Data screening and cleaning procedures did not identify any significant data issues.
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The mitigation of the source data being collected in accordance with good clinical
practices that included electronic data entry with built-in edit checks and regular
monitoring by the sponsor reduced concerns associated with the fact that the data was
collected prior to final quality checks.
The potentially subjective nature of advanced modeling procedures also did not
introduce any unexpected research limitations. The evaluation methodology and
goodness of fit criteria outlined prior to the analysis were implemented without
adjustment. By prespecifying alternative models and variables, the potential for
significant bias to be introduced into model respecification was minimized. Additionally,
all model adjustments were able to be theoretically justified.
Recommendations
Instead of being isolated in QoL research, incorporating response shift assessment
into clinical study design would benefit all clinical investigators that use patient-reported
outcomes as endpoints. Due to the potential for response shift phenomenon to invalidate
efficacy and treatment effect conclusions, this recommendation applies across research
disciplines. An initial step would be to continue to communicate to researchers the
potential confounding effect of response shift on standard clinical trial design and to
provide tools to detect response shift in specific datasets. Publication in peer-reviewed
journals outside of the QoL discipline would be beneficial. These articles would also
serve to educate regulatory agencies, reimbursement professionals, and medical societies
on the importance of considering response shift in clinical data interpretation.
Additionally, as the body of knowledge concerning response shift adjustment is so
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limited with no validated methodologies available, clinical study designers should give
preference to equivalency and non-inferiority study designs over direct comparisons and
superiority hypotheses. This runs counter to the current emphasis by physicians and
governments on comparative effectiveness research. Equivalence designs often do not
identify a clear treatment preference and the resulting increase in treatment options could
increase rather than decrease health care costs. However, since the trade-off would be
between investigators providing accurate clinical conclusions and the preference of
regulatory and reimbursement professionals, patients would be best served by study
designs that minimize response shift bias until investigators can accurately and
consistently support true change comparisons.
I also advocate additional research into the entire response shift discipline.
Despite being explored for the past decade, response shift phenomenon research is still in
an early stage. Research into the catalysts, antecedents, and mechanisms of response shift
and how to identify and measure these variables would support the theory and foundation
of this phenomenon. To expand the body of knowledge on response shift methodologies,
comparisons of approaches, the validation of methods to accurately adjust for response
shift, and the application of new and existing methods to varied QoL instruments and
medical conditions are needed. Of particular value would be research that directly
compares multiple techniques for response shift identification and quantification in a
population where response shift had been previously characterized. Studies to expand
SEM and other statistical methods that use secondary data analysis, the development of
consistent reporting standards, and validated clinical practice guidelines would support
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the practical integration of response shift into research disciplines outside of QoL. My
identification of reprioritization in spine intervention subjects demonstrates that response
shift is important to the accurate interpretation of patient-reported QoL outcome data so I
recommend further research into all aspects of the phenomenon.
Implications for Social Change
The findings of this research provided support for including response shift
evaluation into the clinical interpretation of QoL data to prevent false or inaccurate
conclusions. The understanding that time can serve as a catalyst for response shift in a
spine intervention population will support improved QoL adjustments for individuals
living with chronic spine conditions. This study also provided clinical investigators
outside of the QoL discipline with a practical methodology for evaluating the clinical
significance of response shift on previously collected data. These additions to the
response shift body of knowledge support an increased understanding of how this
phenomenon can confound or invalidate accepted clinical study data interpretation. This
insight can support physicians in coming to accurate clinical conclusions and enhance
clinical decision-making. The incorporation of response shift evaluation into clinical
study design will support the accurate interpretation of clinical trial data and translate into
improved health outcomes for patients worldwide.
Conclusion
Using this research, I investigated the impact of response shift on the clinical
interpretation of comparative data in a spine intervention clinical study. Response shift
phenomenon can interfere with clinical data interpretation when patients adjust the
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framework they use to score their QoL at different occasions. While response shift has
been identified in health care data, the impact in interventional spine studies had not been
studied. Using SEM, which could be applied to previously collected data, I identified a
significant difference in response shift between the 3-month and 12-month follow-ups; a
finding that could invalidate conclusions based on a direct comparison of QoL scores at
these timepoints. However, since no difference in response shift associated with
treatment group at 12 months was identified, a direct comparison of the results was
appropriate. These findings should be considered when assessing ISISS secondary
endpoints but do not impact the primary study analysis as intervention success by patient
served as the primary outcome variable. Success was determined based on a combination
of individual clinically significant improvement, postintervention treatments, and adverse
events.
When treatment effects are being quantified based on patient-reported measures,
clinical investigators should incorporate the assessment of response shift into the
interpretation of the clinical data. Failure to investigate this phenomenon could result in
inaccurate conclusions due to under- or overestimating treatment effects. SEM can be
used to perform this assessment and to further explore the impact of response shift on
clinical study results and conclusions.
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Appendix C: Fit Indices for Model 2.1

Model
2.1

2.1.1a
2.1.1b
2.1.1c
2.1.1d
2.1.1e
2.1.1f

2.1.2a
2.1.2b
2.1.2c
2.1.2d
2.1.2e

2.1.3a
2.1.3b
2.1.3c
2.1.3d

2.1.4a
2.1.4b
2.1.4c

Model
Change
All variables
constrained

2

χ
426.7

df
128

RMSEA
0.096

χ2
DIFF

df
DIFF

Comparison to Model 2.1
Level of significance = α* = αf/(nznt); 0.05/6 = 0.0083
ZCQ2 freed 411.60 126
0.093
15.05
2
BVAS freed 410.43 126
0.093
16.22
2
PF freed
417.09 126
0.094
9.56
2
BP freed
405.30 126
0.092
21.35
2
RE freed
395.26 124
0.091
31.39
4
0.093
15.69
2
MH freed
410.96 126
Variable RE freed
Comparison to Model 2.1.1e
Level of significance = α* = αf/(nznt); 0.05/5 = 0.01
0.090
14.08
2
ZCQ2 freed 381.18 122
BVAS freed 379.63 122
0.090
15.63
2
PF freed
386.81 122
0.091
8.43
2
BP freed
375.72 122
0.089
19.54
2
MH freed
387.52 122
0.091
7.74
2
Variable BP freed
Comparison to Model 2.1.2d
Level of significance = α* = αf/(nznt); 0.05/4 = 0.0125
ZCQ2 freed 350.09 120
0.085
25.63
2
BVAS freed 357.34 120
0.087
18.38
2
PF freed
361.16 120
0.087
14.56
2
MH freed
368.36 120
0.089
7.36
2
Variable ZCQ2 freed
Comparison to Model 2.1.3a
Level of significance = α* = αf/(nznt); 0.05/3 = 0.0167
BVAS freed 321.94 118
0.081
28.15
2
PF freed
321.81 118
0.080
28.28
2
MH freed
343.98 118
0.085
6.11
2
Variable PF freed

p

0.0005*
0.0003*
0.0084
<0.0001*
<0.0001*
0.0004*

0.0009*
0.0004*
0.0146
<0.0001*
0.0209

<0.0001*
<0.0001*
0.0007*
0.0252

<0.0001*
<0.0001*
0.0471

139
Model

2.1.5a
2.1.5b

2.1.6a

Model
Change

χ2

df

RMSEA

χ2
DIFF

df

Comparison to Model 2.1.4b
Level of significance = α* = αf/(nznt); 0.05/2 = 0.025
BVAS freed 286.05 116
0.075
35.76
2
MH freed
316.93 116
0.081
4.88
2
Variable BVAS freed
Comparison to Model 2.1.5a
Level of significance = α* = αf/(nznt); 0.05/1 = 0.05
MH freed
282.32 114
0.075
3.73
2
Variable MH not freed - χ2 DIFF not significant

p

<0.0001*
0.0872

0.1549

Note. ZCQ2 = Zurich Claudication Questionnaire Part 2; BVAS = Back Visual Analog
Scale; PF = Physical Function; BP = Bodily Pain; RE = Role Emotional; MH = Mental
Health; RMSEA = root mean square error of approximation; χ2DIFF = chi-square
difference; df DIFF = degree of freedom difference.
* p significant at adjusted level.
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Appendix D: Model 3.1F LISREL Standardized Path Diagram and Output File
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